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ABSTRACT 
 
Tinnitus is a phantom sensation of sounds in the absence of external acoustic 
stimuli. This hearing abnormality can be caused by ototoxic drugs such as sodium 
salicylate (SS) and lead to emotional responses such as stress. It is likely that tinnitus is 
caused by a change in the activity in the central nervous system, which is dependent on 
excitatory/inhibitory neurotransmission. Gamma-aminobutryic acid (GABA) is the main 
inhibitory neurotransmitter in the brain that activates type-B GABAergic (GABAB 
receptors), which in turn can regulate the excitation/inhibition throughout the nervous 
system. I hypothesize that there will be a change in the GABAB receptors in the rat’s 
nervous system, specifically in the limbic system which is responsible for emotion and 
stress. Immunohistochemistry results indicate an increase in the level of GABAB 
receptors after SS exposure. Tinnitus is commonly understood to cause an increase in 
activity in the central nervous system. An increase in GABAB receptors can be indicative 
of an increase in pre-synaptic GABAB receptors, which regulate the release the GABA.  
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1. Introduction  
1.1 Hearing and hearing abnormalities  
Hearing is the ability of an organism to sense and perceive sound vibrations. It is 
one of the five basic senses (Carlson, 2001). Hearing is important for the biological 
fitness of animals, including humans. It is required by many animal behaviours such as 
mating and social communication. Hearing is not only dependent on the ears but also 
dependent on a group of brain structures collectively called the central auditory system 
(Pickles, 2012).  
Structural, neurochemical, and neurophysiological changes in the ear and/or the 
central auditory system can lead to hearing abnormalities, such as deafness, hyperacusis, 
and tinnitus. While hyperacusis is heightened sensitivity to sound, tinnitus is phantom 
sensation of sound in the absence of external acoustic stimulation (See section 1.7 for 
details). 
Recent studies indicate that auditory neural processing centers receive inputs from 
other brain regions such as limbic structures (Kraus and Canlon, 2012). In individuals 
with tinnitus, the neural activity increases in limbic structures. Due to the neural 
connectivity, changes in the inputs from these structures can affect neural responses in 
the auditory system, which can also lead to hearing abnormalities (Kraus and Canlon, 
2012; Chen et al., 2014).  
1.2 The auditory periphery 
 The peripheral auditory system, i.e., the ear, consists of the outer, middle, and 
inner ears. The outer ear consists of the pinna and the ear canal. The middle ear contains 
three oscicles, i.e., the malleus, incus, and stapes. The inner ear contains the cochlea, a 
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spiral-shaped structure that has the appearance of a coiled snail’s shell (Silverthorn, 2007; 
The peripheral auditory system, 2016).  
The cochlea has a hard bony shell encompassing a membranous system. The 
membrane important for sensory transduction, i.e., the conversion of mechanical 
vibrations into electrical neural signals, is called the basilar membrane. The basilar 
membrane separates the fluid-filled interior of the cochlea into two major parts. The 
lower part is called the scala tympani and is filled with perilymph, which is low in K+ 
concentration and high in Na+ concentration (Johnstone and Sellick, 1972; The peripheral 
auditory system, 2016).  The upper part is further divided by the Reissner’s membrane 
into two compartments. The top compartment is known as the scala vestibule, which 
contains perilymph in similar concentration to the scala tympani. The other compartment 
is known as the scala media, which contains endolymph that is high in K+ concentration 
and low in Na+ concentration (Bosher and Warren, 1968).  
The Organ of Corti is an auditory sensory organ that is found in the basilar 
membrane. It has two types of mechanoreceptor cells: inner hair cells (IHCs) and outer 
hair cells (OHCs). These mechanoreceptors have stereocilia on their apical surfaces. The 
stereocilia are connected to one another by tip-links. When a sound reaches the ear, it 
eventually vibrates the basilar membrane and an overlaying membrane named tectorial 
membrane. The relative movements between the two membranes cause the stereocilia of 
hair cells to bend and mechanical force-gated ion channels attached to the tip-links to 
open. K+ ions then flux from the endolymph into a hair cell, causing depolarization of the 
cell (Hudspeth, 1982; The peripheral auditory system, 2016). In this way, mechanical 
signals are transduced (i.e., converted) into electrical signals, which can be sent through 
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the cochlear nerve to the central auditory system (CAS) for processing (Silverthron, 
2007).  
1.3 The central auditory system (CAS): Major structures and interconnections 
 There are six major structures in the central nervous system with primary 
functions related to hearing. These structures include the cochlear nucleus (CN), superior 
olivary complex (SOC), nucleus of lateral lemniscus (NLL), inferior colliculus (IC), 
medial geniculate nucleus (MGN), and the auditory cortex (AC). These six major 
auditory structures form an ascending pathway, with CN at the bottom receiving auditory 
signals from the cochlea in the inner ear and the AC at the top of the hierarchy. Such a 
hierarchy has been conserved in mammals throughout evolution and thus a homology to 
humans exists (Figure 1).  
1.3.1 Ascending auditory pathway  
1.3.1.1 Cochlear nucleus (CN) 
 The first brainstem auditory structure along the ascending pathway is the CN 
(Figure 2). It consists of two major subdivisions, the dorsal CN (DCN) and the ventral 
CN (VCN). The VCN can be further subdivided into the anterior VCN (AVCN) and 
posterior VCN (PVCN) (Malmierca and Merchan, 2005). The CN receives direct inputs 
from the peripheral auditory system through the auditory nerve (i.e., the 8th cranial 
nerve). It sends projections to the SOC, NLL, IC, and MGN (Schofield and Coomes, 
2005). There are different cell types in each subdivision of the CN. These cells have 
different cell morphology and temporal patterns of action potential discharge in response 
to acoustic stimulation. For instance, globular and spherical bushy cells in the AVCN fire  
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Figure 1: Visual representation of the ascending and descending projections in the 
nervous system a human and rat brain. (A) Visual representation of the ascending 
projections found in the human brain (left) and the rat brain (right). (B) descending 
projections found in the human brain (left) and the rat brain (right). [Courtesy of Dina 
Kokh].  
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over the whole duration of a stimulus. Octopus cells found in the PVCN only fire at the 
onset of a stimulus. Fusiform and pyramidal cells in the DCN fire at the offset of a 
stimulus (Gil-Layzaga et al., 2013). The CN is involved in analyzing the intensity, 
duration, and on- and offset of an acoustic stimulus (Gil-Layzaga et al., 2013). 
1.3.1.2 Superior olivary complex (SOC) 
 The SOC is the second brainstem structure along the ascending auditory pathway 
(Figure 2). The SOC is composed of six small subdivisions (Malmierca and Merchan, 
2005). These subdivisions include the lateral nucleus of the trapezoidal body (LNTB), the 
ventral nucleus of trapezoidal body (VNTB), the medial nucleus of the trapezoidal body 
(MNTB), the lateral superior olivary nucleus (LSO), the medial superior olivary nucleus 
(MSO), and the superior paraolivary nucleus (SPN). SOC receives inputs from the CN 
and sends projections to the NLL and IC (van Adel and Kelly, 1998). Major functions of 
the SOC are related to the localization of sounds (van Adel and Kelly, 1998). Two of the 
major subdivisions, the MSO and LSO, are especially important for these functions. 
While the MSO is critical for localizing sounds by using interaural-time difference (ITD) 
cues, the LSO is essential for localizing sounds by using interaural-level difference (ILD) 
cues (Tollin, 2003). Other functions of the SOC are related to the suppression of echoes 
of sounds from the environment (Malmierca and Merchan, 2005).  
1.3.1.3 Nucleus of the lateral lemniscus (NLL) 
 The NLL is the last brainstem structure along the ascending auditory pathway 
(Figure 2). This structure consists of two different groups of neurons associated with two 
different innervation patterns. Neurons in the ventral NLL (VNLL) receive inputs driven  
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Figure 2: Schematic diagram showing the major ascending projections in the central 
auditory structures. Abbreviations: AC: auditory cortex, MG: medial geniculate body, 
IC: inferior colliculus, NLL: nucleus of lateral lemniscus, SOC: superior olivary 
complex, CN: cochlear nucleus [Modified from Winer and Schreiner, 2005].  
 
 
 
 
 
 7 
by only the ear on the contralateral side. These monaural neurons are involved in 
processing temporal characteristics of sounds (Gil-Layzaga et al., 2013). Neurons in the 
dorsal NLL (DNLL) receive diverse inputs, with some of them driven by the contralateral 
ear while others diven by both ears. Neurons in the DNLL are involved in sound 
localization (Aitkin et al., 1970; Bruggae et al., 1970, Bajo et al., 1998; Gil-Layzaga et 
al., 2013).  
1.3.1.4 Inferior Colliculus (IC) 
 The IC is a midbrain auditory structure (Figure 2). It receives projections from all 
the major brainstem structures (CN, SOC, and NLL) and forebrain structures (MGN and 
AC, see section 1.3.1.5 and 1.3.1.6). The IC is the primary source of projections for the 
MGN, which relays auditory information to the AC (Malmierca and Merchan, 2005). The 
IC includes three subdivisions: the central nucleus of the IC (ICc), the dorsal cortex of the 
IC (ICd), and the external cortex of the IC (ICx). Neurons in the ICc are organized in 
such a way, that neurons sensitive to low frequencies are located in the dorsolateral parts 
while neurons sensitive to high frequencies are located in the ventromedial part of the 
structure. This topographic organization (i.e., tonotopic organization) allows for 
processing of frequency information of sound. Among other acoustic characteristics 
processed by the ICc are the ITD and ILD. The involvement of this collicular subdivision 
in processing these aboustic characteristics suggests that it contributes to the localization 
of sounds (Gil-Layzaga et al., 2013). The ICd and ICx are involved in processing higher 
order information, such as language and identifying novel sounds. 
1.3.1.5 Medial geniculate nucleus (MGN) 
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The MGN is a thalamic structure and it is the only structure that sends direct 
projections to the AC (Figure 2). The MGN, along with the AC, is a forebrain auditory 
structure. The MGN can be subdivided into the ventral division of the MGN (MGv), the 
dorsal division of the MGN (MGd), and medial division of the MGN (MGm).  
The MGv 
 The MGv receives major projections from the contralateral ICc and ipsilateral 
ICc, ICd, and ICx (Bordi and LeDoux, 1994; Gonzalez-Hernandez et al., 1991; 
Malmierca and Merchan, 2005). It sends projections to the AC as well as the IC (Winer 
and Schreiner, 2005). The MGv is involved in the processing of basic characteristics of 
sounds including temporal structures and frequency content (Bordi and LeDoux, 1994). 
The MGd 
 The MGd receives projections from the ICd, ICx, and somatosensory system 
(Winer, 1985). It sends projections to the ICx and secondary AC areas (Winer, 1992; 
Malmiera and Merchan, 2004). The main function of the MGd is most likely related to 
the processing of complex sounds, including the recognition of sound patterns (Bordi and 
LeDoux, 1994).  
The MGm 
 The MGm is a small subdivision receiving projections from many structures. It 
provides outputs to a variety of other structures. Auditory input projections include those 
from the ICx, ICd, CN, SOC, VNLL, and the reticular thalamic nucleus (Winer, 2005). 
The MGm communicates with structures outside the major auditory pathway, which 
include the somatosensory cortex (Spreafico et al., 1981), visual system (Malmierca et 
al., 2002), and the amygdala (Otterson and Ben-Ari, 1979; Otterson, 1981; LeDoux, 
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1985, 1987). The complex connections render the MGNm a variety of functions. It is 
believed that the structure is involved in multisensory integration (Bordi and LeDoux, 
1994) and processing of emotional characteristics of sounds (LeDoux et al., 1984). 
1.3.1.6 Auditory Cortex (AC) 
 The AC is a part of the temporal cortex. Along with the MGN, the AC is a key 
forebrain auditory center (Figure 2). It can be subdivided into the primary auditory cortex 
(A1), the secondary auditory cortex (A2), and association auditory cortices. The A1 is 
sometimes also referred to as the core area of the auditory cortex, while the other areas 
are sometimes also referred to as the belt areas (Gil-Layzaga et al., 2013). The AC can be 
subdivided into six layers. From the surface to the deep part of the structures are layers I 
through VI (Gil-Layzaga et al., 2013). The AC plays a critical role in the sensation, 
perception, and cognition of sounds (Gaese and Ostwald, 1995). Neurons in the A1 are 
arranged topographically based on frequency that they best respond to. The ones that 
respond best to low frequencies correspond to the apex of the cochlea and the ones that 
respond best to high frequencies correspond to the base of the cochlea. Such a tonotopic 
organization is important for the processing of frequency information of sounds. The belt 
areas of the AC do not have tonotopic organizations. Neurons in this subarea are involved 
in sound localization, auditory memory, and understanding complex sounds such as 
language. Neurons in the belt regions also contributes to the integration of auditory 
information with other sensory systems (Gil-Layzaga et al., 2013). 
1.3.2 Descending and commissural projections in the central auditory system 
 Major auditory structures not only provide ascending projections to higher 
structures in the hierarchy of the auditory system, they also provide descending  
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Figure 3: Schematic diagram showing the major descending projections in the 
central auditory system. Abbreviations: AC: auditory cortex, MG: medial geniculate 
body, IC: inferior colliculus, NLL: nucleus of lateral lemniscus, SOC: superior olivary 
complex, CN: cochlear nucleus [Modified from Winer and Schreiner, 2005]. 
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projections to lower structures and commissural projections to the contralateral side of 
the brain (Figure 3).  
1.3.2.1 Major structures providing descending projections  
1.3.2.1.1 Auditory cortex (AC)  
Being at the very top of the hierarchal auditory pathway, the auditory cortex sends 
many descending projections to other structures.  Neurons from both layer V and VI send 
ipsilateral projections to the MGNv and MGNd (Winer and Prieto, 2001). Neurons in the 
layer V of the AC also send descending projections to the IC (Schofield, 2009). These 
cortico-collicluar connections are of critical importance for auditory processing. 
Projections from the AC are also sent to the CN (Schofield and Coomes, 2005).  
1.3.2.1.2 Medial geniculate nucleus (MGN)  
 The MGN does not send many descending projections. However, there are some 
ipsilateral projections to the IC. Specifically, these projections are sent to the ICx 
subdivision of the IC (Malmierca et al., 1999).  
1.3.2.1.3 Inferior colliculus (IC)  
The IC sends descending projections to the CN (Schofield and Coomes, 2005). It 
can send projections further downward to the periolivary medial olivocochlear cells, 
which are cells that innervate the OHCs (Faye-lund, 1986; Caicedo and Herbert, 1993; 
Saldana, 1993; Vetter et al., 1993).  
1.3.2.1.4 Nucleus of lateral lemniscus (NLL)  
 The NLL is a small structure that does not have many descending projections. The 
CN is the only one auditory structure that receives descending projections from the NLL 
(Schofield and Coomes, 2005). 
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1.3.2.1.5 Superior olivary complex (SOC)  
 The only central target structure of descending projections from the SOC is the 
CN (Schofield and Coomes, 2005). Descending neural projections from the SOC are also 
sent to the cochlea of the inner ear. These projections provide protection to sensory 
receptor cells in the cochlea. When these cochlear cells are exposed to a loud sound 
(>80dB), the descending projections from the SOC provide signals to cause middle ear 
muscles to contract and the basilar membrane to become rigid, thereby reducing the 
movement of the basilar membrane and decreasing the energy being provided to the inner 
ear (Gil-Layzaga et al., 2013). 
1.3.2.1.6 Cochlear nucleus (CN) 
 The CN is at the very bottom of the hierarchy. Due to this, it does not provide any 
descending projections to other central auditory structures. However, it is one of 
structures that receive many descending projections. It receives projections from the AC, 
IC, and SOC (Schofield and Coomes, 2005).  
1.3.2.2 Major commissural projections 
 Commissural projections exist throughout the CNS. These are projections that 
connect structures from both sides by crossing the midline (Gonzalez-Hernandez et al., 
1986; Saldana and Merchan, 1992). The mammalian forebrain consists of two main 
cortical hemispheres. Interconnections exist between the two due to major white matter 
tracts, known as the corpus callosum (Robichaux et al., 2016). There exists commissure 
of Probst that are found between the DNLL of both sides and also from the DNLL to the 
ICc. Binaural responses in DNLL are mostly influenced by these projections (Beyerl, 
1978; Adams, 1979; Zook and Casseday, 1982; Bajo et al., 1993; Merchan et al., 1994). 
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There also exist commissure projections between the two IC structures on both sides of 
the brain. These are known as the commissure of the inferior colliculus and include many 
excitatory fibres and some inhibitory fibres(Hernandez et al., 2006).  
1.4 The limbic system and its relation with the auditory system 
The auditory system is regulated by other systems in the brain. Such regulation 
aids in hearing (Galazyuk et al., 2012; Kraus and Canlon, 2012). The systems involved in 
the regulation of auditory functions include the limbic system (Figure 4). Existing 
evidence indicate that major limbic structures including the amygdala and hippocampus 
either directly or indirectly innervate auditory structures including the MG and IC 
(Moller and Rollins, 2001; Kraus and Canlon, 2012). The projections to the MG are 
likely involved in the gating of auditory signals relayed from the MG to the AC (Muhlau 
et al., 2006; Rauschecker et al., 2010). The MGN sends direct projections to the 
amygdala, which innervates the hippocampus. The hippocampus sends direct projections 
to the amygdala, which innervates the IC (Kraus and Canlon, 2012). The reciprocal 
innervations between the auditory and limbic system provide structural bases of limbic 
regulation of hearing. 
1.4.1 Amygdala  
 The amygdala is an almond-shaped structure found in the temporal lobe of the 
brain. The structure is well known for its role in emotions such as stress (Sah et al., 
2003). Besides, the structure is involved in the processing of information related to all 
major sensory modalities including audition, olfaction, somatosensation, gustation, and 
vision (Sah et al., 2003). The amygdala can be subdivided into four subdivisions (Figure 
5): the lateral nucleus (LaN), central nucleus (CeN), basolateral nucleus (BLN), and  
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Figure 4: Neural connectivity between auditory and limbic systems. Green: represents 
the auditory structures. Purple: represents the amygdala. Blue: represents the 
hippocampus. [Kraus and Canlon, 2012] 
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Figure 5: Major subdivisions in the amygdala. Blue: represents the lateral and 
basolateral subdivisions. Green: represents the central and basomedial subdivisions. [Sah 
et al., 2003] 
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basomedial nucleus (BMN) of the amygdala (Le Doux, 2007). These subdivisions differ 
in cytoarchitectonics and connectivity (Krettek and Price, 1978; Pitkanen, 2000).  
Basolateral Amygdala (BLA) 
The BLA, sometimes referred to as the basal amygdala, receives major 
projections form the subicular regions of the hippocampus (see below).  Among all the 
amygdaloid subnuclei, the BLA is the main target for fiber projections from the 
hippocampus (Canteras and Swanson, 1992). The BLA sends projections to the 
hippocampus, prefrontal cortex, nucleus accumbens, and the thalamus (Pare et al., 1995).  
 The cells of the BLA have been well defined based on Golgi impregnation 
staining. Almost 70% of the cells in the BLA are pyramidal cells (Hall, 1972; Millhouse 
and DeOlmos, 1983; Washburn and Moises, 1992). These pyramidal neurons have 
randomly oriented apical dendrites (McDonald, 1992; Rainnie et al., 1993; Pare et al., 
1995; Faber et al., 2001). The second types of cells found in the BLA look like the 
nonspiny stellate cells found in the neocortex (Hall, 1972). Other cells found in the BLA 
include the extended neurons, cone cells, chandelier cells, and neurogliaform cells 
(Faulkner and Brown, 1999; Kamal and Tombol, 1975; McDonald, 1982).  
Lateral nucleus of the amygdala (LaN) 
The LaN serves as a point of entry of the amygdala. Most of the structures 
innervating the amygdala contact the LaN, which relays neural signals to the other 
subdivisions of the amygdala (Sah et al., 2003). The LaN receives inputs from MGN 
(LeDoux et al., 1990; LeDoux et al., 1991; Turner and Herkenham, 1991). Retrograde 
tract-tracing studies revealed no direct projections from the Te1 to the amygdala 
(Mascagni et al., 1993; Shi and Cassell, 2001). However, projections from other cortical 
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regions such as Te3 to the LaN do exist (LeDoux et al., 1991; Shi and Cassell, 2001). In 
addition to these connections with forebrain auditory structures, the LaN has connections 
with brain areas responsible for long-term memory. These areas include the perirhinal 
cortex, entorhinal cortex, parahippocampal cortex, and the hippocampus (Macdonald, 
1998; Milner et al., 1998; Pitkanen et al., 2000). 
 The cell types found in the LaN are quite similar to those found in the BLA. 
Generally, cells in the LaN are smaller than those in the BLA. The cells in the LaN have 
an average soma size of 10-15µm, whereas the cells in the BLA have an average soma 
size of 15-20µm (McDonald, 1982; Millhouse and DeOlmos, 1983). 
Basomedial amygdala (BMA)  
 The BMA receives fiber innervations from the LaN and BLA (Sah et al., 2003). It 
sends fiber outputs to the CeN, which acts as the output station and relays neural signals 
to other structures in various regions of the CNS, including the auditory system (Pitkanen 
et al., 1997). 
 There is only one known cell type in the BMA. These cells have relatively small 
or medium sizes and ovoid shapes. Most neurons have two to four spiny primary 
dendrites in this structure (McDonald, 1992).  
Central nucleus of the amygdala (CeN) 
 The CeN sends projections to many target structures that are responsible for 
various different functions. Among these targets, the hypothalamic nucleus is involved in 
the activation of the autonomic system (Kapp et al., 1982; LeDoux et al., 1988). Other 
target structures include the periaqueductal gray, which can modify vocal and 
cardiovascular functions (Behbehani, 1995; Rizvi et al., 1991). The parabrachial nucleus  
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Figure 6: Major subdivisions in the hippocampus. (A) shows a rostral slice of the 
hippocampus. Major subdivisions are colour coordinated with the legend at the bottom. 
(B) shows a caudal slice of the hippocampus. Major subdivisions are colour coordinated 
with the legend at the bottom. [Modified from Kjonigsen et al., 2011] 
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is involved in pain processing (Gauriau and Bernard, 2002; Moga and Gray, 1985). In 
addition, the CeN also send fiber projections to the stria terminalis (Dong et al., 2001) 
and nuclei in the midbrain, pons, and medulla (Veening et al., 1984).  
 There are three different cell populations in the CeN. The predominant cell type is 
known as the medium spiny neurons (McDonald, 1982; Hall, 1972). Another type has 
larger soma than the medium spiny neurons and a thick aspiny dendrite (Schiess et al., 
1999; Cassell and Gray, 1989). The third type of neurons are aspiny neurons. They exist 
throughout the CeN but are small in number (Cassell and Gray, 1989). The three types of 
cells exist homogenously throughout the CeN (Sah et al., 2003).  
1.4.2 Hippocampus  
The major function of the hippocampus is related to the formation of memory 
(Tulving and Markowitsch, 1998), although the structure is also involved in other high 
functions such as stress (McEwen, 1999). 
 The structure receives projections from other structures. One of these other 
structures is the amygdala, which sends many projections to the different subdivisons of 
the hippocampus (Ottersen, 1982; Kishi et al., 2006; Cenquizca and Swanson, 2007). 
Target structures of projections from the hippocampus include olfactory bulb 
(Cenquizca and Swanson, 2007), primary visual cortex (Miller and Vogt, 1984), 
entorhinal cortex (Burwell and Amaral, 1998), and hippocampal formation (Verwer et al., 
1997). Major subdivisions of the hippocampus include the cornus ammonis 1-3 (CA1-
CA3), dentate gyrus (DG), and subicular area (SUB) (Figure 6) (O’Mara, 2005; Amaral 
et al., 2007; Mohedano-Moriano et al., 2007). The CA1-CA3 and the DG are collectively  
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called the hippocampus proper, while the SUB is sometimes also referred to as the 
hippocampal formation.  
Cornus ammonis 1 (CA1) 
The CA1 is a large part of the hippocampus proper. Extensive projections have 
been found between this area and other neural subdivisions and structures. Major 
projections to CA1 are from other regions of the hippocampus and subdivisions of the 
amygdala. Strong projections originating from within the hippocampus to the CA1 
include those from the CA3 (Swanson and Cowan, 1977) and subicular region, 
specifically the dorsal SUB (Witter et al., 1990). Strong projections originating from 
outside the hippocampus include those from the BMA (Canteras et al., 1992) and BLA 
(Savander et al., 1995) of the amygdala. Moderate projections to CA1 are from the LaN 
(Petrovich et al., 2001), while weak projections to CA1 are from the dentate gyrus 
(Swanson et al., 1978).   
The CA1 sends projections to the four major amygdaloid subdvisions including 
the BLA, BMA, CeN, and LaN (Ottersen, 1982; Kishi et al., 2006; Cenquizca and 
Swanson, 2007). The CA1 provides weak projections to the primary auditory cortex 
(Paperna and Malach, 1991). 
 Pyramidal cells are the main type of cells found in the CA1 area. The pyramidal 
cells found in the CA1 are morphologically identifiable specifically as CA1 pyramidal 
cells. They differ in cytoarchitecture from  from other pyramidal cells found throughout 
the hippocampus, i.e CA2-CA3, SUB pyramidal cells (Amaral and Lavenex, 2007).   
Cornus ammonis 2 (CA2)  
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 The CA2 is found between CA1 and CA3 and is the smallest region of the 
hippocampus proper. It is not studied as extensively as the other subdivisions. 
Nevertheless, there evidence showing that the CA2 has projections to and from other 
structures. Most incoming projections are from the amygdala, specifically the BLA and 
BMA (Petrovich et al., 2001). Neurons in the CA2 project to the SUBd (Swanson and 
Cowan, 1977). Other projections from the CA2 are relatively moderate/weak. Targets of 
these projections include the primary auditory cortex (Paperna and Malach, 1991), 
primary motor cortex (Reep et al., 1990), and primary visual cortex (Miller and Vogt, 
1984).  
 The major type of cells in the CA2 are pyramidal cells. Morphologically these 
appear smaller than the pyramidal cells found in the CA1, CA3, and SUB regions. This 
allows for identification of CA2 pyramidal cells to be made possible. (Amaral and 
Lavenex, 2007).   
Cornus ammonis 3 (CA3)  
 The CA3 covers a larger area of the hippocampus proper. Major projections to 
this hippocampal region include those from other hippocampal regions and from 
structures outside the hippocampus. Other hippocampal regions providing projections to 
the CA3 include the dentate gyrus (Swanson et al., 1978), the subiculum (Kohler, 1985), 
and the CA1 (Swanson et al., 1981). Non-hippocampal regions sending major projections 
to the CA3 include the BLA and BMA of the amygdala (Pikkarainen et al., 1999). The 
CA3 sends projections to the CA1, ventral and dorsal SUB, CA2, and dentate gyrus 
(Swanson and Cowan, 1977). CA3 also send projections to the olfactory bulb, dorsal 
auditory cortex (Swanson and Cowan, 1977), and the visual cortex (Miller and Vogt, 
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1984). Furthermore, projections from CA3 are sent to the BLA and BMA of the 
amygdala (Swanson and Cowan, 1977). 
 The CA3 pyramidal cells are the main type of cells found in the CA3 region. 
These cells branch out more than those found in CA1-CA2 regions (Amaral and Lavenex, 
2007).   
Dentate Gyrus (DG) 
 The DG is the largest subdivision within the hippocampus proper. Inputs to the 
DG include those from the CA3 (Swanson and Cowan, 1977) and subiculum (Kohler, 
1985). The BLA, BMA, and CeN of the amygdala also send projections to the dentate 
gyrus (Petrovich et al., 2001). Major projections from the DG are sent to the CA3. 
Projections are also sent to the subiculum and CA1 (Swanson et al., 1978) as well as to 
the BLA and LaN regions of the amygdala (Ottersen, 1982).  
 Granule cells are the main type of cells in the DG. These cells are 
morphologically very different from pyramidal cells found in other areas of the 
hippocampus. Granule cells in the DG are not as densely packed and have different 
orientations, in contrast to pyramidal cells in other hippocampal regions, which are 
aligned with similar orientations in a thin sheet (Amaral and Lavenex, 2007).   
Subiculum  
 The subiculum is considered to be a part of the hippocampus. However, it is not a 
part of the hippocampus proper. The subiculum can be further subdivided into the dorsal 
subiculum (SUBd) and the ventral subiculum (SUBv) (Verwer et al., 1997; Cenquizca 
and Swanson, 2007). Differences exist between the two regions of the subiculum in fiber 
innervation.  
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The SUBd receives projections from the CA2 (Swanson and Cowan, 1977), CA3 
(Swanson and Cowan, 1977), and DG (Swanson et al., 1978). The SUBd sends 
projections to the CA1 and the SUBv (Swanson and Cowan, 1977). It also sends 
projections to the BLA and BMA. Also, weak projections are provided by the subiculum 
to the dorsal auditory cortex (Witter et al., 1990).  
The SUBv receives projections from the CA3 (Swanson and Cowan, 1977) and 
DG (Swanson et al., 1978). The SUBv sends major projections to the amygdala, 
including the BLA, BMA (Kishi et al., 2006), LaN (Ottersen, 1982), and CeN (Canteras 
and Swanson, 1992). 
 Projecting pyramidal cells are the major type of cells found in the SUB. These 
cells are not as densely packed as the pyramidal cells in the CA1-CA3 region. However, 
they do have a specific aligned orientations as seen in those regions. (Amaral and 
Lavenex, 2007).   
1.4.3 Auditory-limbic connections 
 The auditory and limbic structures are connected with one another through some 
major areas. Overall, the auditory structures form direct connections with the amygdala 
and indirect connections with the hippocampus (Kraus and Canlon, 2012). The MGN is 
the key structure that sends direct projections to the LaN of the amygdala (Graybiel, 
1972; Aitkin, 1986). The AC sends projections to the LaN (Kraus and Canlon, 2012).  
The LaN then sends projections to the BLA, which sends direct projections to the CA1, 
CA3 and indirect connections to the SUB (Kraus and Canlon, 2012). 
 Projections towards the auditory system from the limbic system involve direct 
projections from the amygdala and indirect projections from the hippocampus. The CA1 
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and SUB send projections to the LaN, BMA, and BLA in the amygdala. The BLA then 
sends direct projections to the IC in the auditory pathway (Sah et al., 2003; LeDoux, 
2007; Kraus and Canlon, 2012).   
1.5 Neurotransmission in the central nervous system  
 Relay of signals from one neuron to the next is dependent on a synapse. At a 
synapse, molecules of a specific neurotransmitter are released from a presynaptic 
terminal and bind onto postsynaptic neurotransmitter receptors. There are a variety of 
neurotransmitters found in the CNS including glutamate and gamma-aminobutryic acid 
(GABA) (Silverthorn, 2013).  
Neurotransmitter receptors can be either ionotropic or metabotropic. An 
ionotropic receptor is also an ion channel. When bound by a neurotransmitter, such a 
receptor opens the ion channel and allows for the movement of ions across the cell 
membrane. An ion flux changes the membrane potential, leading to either an excitatory or 
inhibitory effect depending on the species of ions moving across the cell membrane. 
Generally, such an ion flux and membrane voltage change is short-lived (Purves et al., 
2001; Silverthorn, 2013).  
 A metabotropic receptor itself is not an ion channel. Such a receptor is coupled to 
a guanine nucleotide-binding protein (G-protein). When a neurotransmitter molecule 
binds onto the receptor, G-protein molecules are activated. Subunits of the G-protein 
dissociate from each other. Dissociated G-protein subunits can directly modify ion 
channels to either enhance or reduce their opening probability. The subunits can also 
activate target proteins to produce second messengers, which in turn can initiate various 
intracellular signaling cascades and lead to modification of ion channels. As a result, 
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opening probabilities of these ion channels can be enhanced or suppressed. Enhanced or 
suppressed ion fluxes can change the cell membrane voltage. Thus, a cell can be excited 
or inhibited. Multiple steps between the activation of a metabotropic receptor and 
changes in the opening probability of ion channels lead to a slow and long-lived 
membrane voltage alteration (Purves et al, 2001; Silverthorn, 2013). Furthermore, 
binding between one single receptor by a neurotransmitter can affect multiple ion 
channels.  
1.5.1 Glutamatergic neurotransmission 
 Glutamate is an amino acid neurotransmitter. Both ionotropic and metabotropic 
glutamatergic receptors exist in the nervous system. Major ionotropic glutamatergic 
receptors include the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptor, the N-methyl-D-aspartic-acid (NMDA) receptor, and the kainate receptor 
(Silverthorn, 2013). Metabotropic glutamate receptors are divided into Group I (mGluR1 
and mGluR5), Group II (mGluR2 and mGluR3), and Group III (mGluR4, mGluR6, 
mGluR7 and mGluR 8) (Ferraguti and Shigemoto, 2006). 
1.5.1.1 AMPA receptors 
 AMPA receptors are permeable to monovalent cations. After binding by 
glutamate, an activated AMPA receptor allows sodium ions to move into a cell and 
potassium ions to leave the cell. At or near the resting potential of a neuron, more sodium 
ions enter the neuron than potassium ions leaving the neurons. The net ion influx leads to 
an excitatory post-synaptic potential (EPSP) and a depolarization of the cell membrane 
(Silverthorn, 2013). 
1.5.1.2 NMDA receptors 
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 The NMDA receptors are different from the other ionotropic glutamatergic 
receptors (i.e., AMPA and kainite receptors) in a few aspects. First, these receptors are 
permeable to not only sodium and potassium ions, but also calcium ions. Second, the 
activation of the receptors is dependent not only on binding by glutamate, but also on 
other factors including binding by a co-agonist glycine and removal of blockage by 
magnesium ions. The later is dependent on membrane depolarization, which is normally 
provided by activation of AMPA receptors on the cell membrane. An activated NMDA 
receptor allows for an influx of sodium and calcium ions and efflux of potassium ions. 
The resulting net influx of cations leads to an EPSP and depolarization of the cell 
membrane. As calcium can serve as a second messenger and affect many aspects of 
intracellular signalling, the permeability of the NMDA receptor to this ion makes the 
effect of activation of the receptor long lasting. It has been found in many structures of 
the brain that tetanic stimulation of synaptic inputs can enhance the excitatory response of 
a neurons and the enhancement of response can last for hours.  Such an enhancement is 
known as long-term potentiation and is largely dependent on the activation of the NMDA 
receptors (Silverthorn, 2013). 
1.5.1.3. Kainate receptors 
 Kainate receptors are similar to AMPA receptors. They exist in many structures 
such as the hippocampus, cortex, spinal cord, and retina. In many cases, kainate receptors 
are co-localized with AMPA and NMDA receptors. However, there are structures in 
which kainate receptors exist without co-localied AMPA and NMDA receptors. These 
structures include the retina, in which a synapse between a cone cell and an off-centre 
bipolar cell is mediated by kainate receptors (Huettner, 2003).  
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1.5.1.4. Metabotropic glutamatergic receptors 
 Metabotropic glutamate receptors are G-protein coupled receptors. These 
receptors are found throughout the mammalian CNS. Activation of a metabotropic 
glutamatergic receptor can lead to either an excitatory or an inhibitory response 
depending on downstream signaling cascades including the specific cell membrane ion 
channels modified (Ferraguti and Shigemoto, 2006).  
1.5.2 GABAergic neurotransmission  
 GABA is a major inhibitory neurotransmitter found throughout the brain 
(Silverthron, 2013). Almost 40% of the synapses in the brain are GABAergic (Malcangio 
et al., 1996).  
 There are three subtypes of receptors to which GABA binds. These three are the 
type-A, type-B, and type-C GABA receptors (GABAA, GABAB, and GABAC receptors) 
(Enna, 2001). GABAA and GABAB receptors are found in all the major central auditory 
processing centres, limbic structures including the amygdala and hippocampus, and 
cerebellum (Chu et al., 1990; Wamsley et al., 1986; McCabe and Wamsley, 1986; Zezula 
et al., 1988; Jamal et al., 2012; Liu et al., 2014). GABAC receptors, however, are mostly 
found in the retina of vertebrae and are believed to be important for the processing of 
visual information (Bormann and Feigesnspan, 1995).   
1.5.2.1 Type-A and type-C GABA receptors  
 Both GABAA and GABAC receptors are ionotropic receptors that are permeable to 
chloride ions upon activation. There are many isoforms of GABAA and GABAC 
receptors. Each functional receptor is made up of five subunits that surround a central 
channel, which is selective for chloride ions. Upon binding by GABA, the channel  
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Figure 7: GABAB receptor mechanism pre- and post-synaptically. After the GABA 
molecule binds to the GABAB receptor, the βϒ-subunit dissociates from the α-subunit. It 
moves to the K+ or Ca2+ channels postsynaptically or presynaptically, respectively, and 
leads to the opening of K+ channels and the closing of Ca2+ channels. [Chalifoux and 
Carter, 2011] 
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Figure 8: Protein conformation of a functional GABAB receptor with both subunits. 
Blue: shows the GABABR1 subunit. Yellow: shows the GABABR2 subunit. Both 
subunits have a venus flytrap (VFT) module and a heptahelical domain (HD). The VFT 
module of the GABABR1 contains an area for GABA binding. The HD of the GABABR2 
contains area associated with the G-protein. [Pin et al., 2003]. 
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becomes open, allowing negatively charged chloride ions to enter the cell and to cause an 
inhibitory post-synaptic potential (IPSP) (Sigel and Steinmann, 2012).    
1.5.2.2 Type-B GABA receptors  
 The GABAB receptor is a metabotropic receptor with more complex functions 
than the ionotropic GABAergic receptors (Benke et al., 1999). GABAB receptors exist at 
both presynaptic and postsynaptic sites. In general, binding of a GABAB receptor by 
GABA leads to activation of a G-protein and subsequent modification of calcium or 
potassium ion channels (Filippov et al., 2000). 
Activation of a presynaptic GABAB receptor can regulate the release of 
neurotransmitters including glutamate and GABA (Scholz and Miller, 1991; Mintz and 
Bean, 1993, Obreitan and Van Den Pol, 1999). Following biunding of a GABAB receptor 
by GABA, a G-protein trimer dissociates into the βϒ-subunit and α-subunit. The βϒ-
subunit modifies a voltage-gated calcium channel, decreasing influx of calcium ions and 
thereby decreasing the release of neurotransmitters (Figure 7) (Herlitze et al., 1996; 
Ikeda, 1996). Activation of postsynaptic GABAB receptors can result in an IPSP. After 
GABA binds to a GABAB receptor, a G-protein dissociates into the βϒ-subunit and α-
subunit. The βϒ-subunit modifies the inward rectifier potassium channels (GIRK), which 
lead to enhanced potassium ion efflux and an IPSP (Figure 7) (Luscher et al., 1997; 
Ulrich and Bettler, 2007).  
1.5.2.2.1 Type-B GABA receptor subunits  
 A functional GABAB receptor is a heterodimer comprised of two subunits, 
GABABR1 and GABABR2 (Kaupmann et al., 1998). The GABABR1 contains a venus 
flytrap (VFT) module, a domain that is capable of binding to the ligand GABA (Figure 8) 
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(Malitschek et al., 1999; Pin et al., 2004). The GABABR2 is coupled with a G-protein at 
its heptahelical domain (HD) (Figure 8) (Robbins et al., 2001; Pin et al., 2004). The 
GABABR1 has a retention signal that keeps it bound to the endoplasmic reticulum after 
the subunit is made (Pin et al., 2004). The two subunits interact with their coiled-coil 
domains. Once a heterodimer is formed between the two subunits, the retention signal is 
masked and the dimeric receptor can be brought towards the plasma membrane to 
become functional (Margeta-Mitrovic et al., 2000; Pagano et al., 2001).  
GABABR1 consists of two splicing variants: GABABR1α and GABABR1β 
(Bowery et al., 2002). They differ in the lengths of their N-terminus. GABABR1α 
contains 163 amino acids in its N-terminus, whereas GABABR1β contains 47 amino 
acids. The levels of the two splicing variants change over different developmental stages. 
GABABR1α is highly expressed before birth, whereas GABABR1β is highly expressed in 
adults (Fritschy et al., 1999). It is possible that GABABR2 has some variants as well, 
however, these have not been characterized yet (Chalifoux and Carter, 2011). 
1.5.2.2 Distribution of Type-B GABA receptors in auditory and limbic systems 
 GABAB receptors are found throughout all the major structures in the central 
auditory system. Structures showing a high level of GABAB receptors include the ICd, 
DCN, MGN, and AC (Fubara et al., 1996; Jamal et al., 2012). Lower levels are found in 
the ventral and lateral parts of the IC, the NLL, the SOC, and ventral part of the CN. The 
GABAB receptors also exist throughout the limbic system including both the 
hippocampus and amygdala. The hippocampus contains GABAB receptors in all 
subdivisions, however, the strongest labeling is found in the CA1 and CA3 pyramidal 
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cells (Kulik et al., 2003). Immunohistochemistry and western blotting experiments have 
confirmed the localization of GABAB receptors in the amygdala (Sah et al., 2003).  
1.6 Neurotransmission and functions of the auditory and limbic systems  
  A balance between excitatory and inhibitory neurotransmission is critical for the 
normal function of the brain. An imbalance between excitation and inhibition can lead to 
changes in neural activity, which can have various behavioural consequences (Bauer et 
al., 1999; Gerken et al., 1984). The pre- and postsynaptic functions of the GABAB 
receptor makes this receptor especially important for regulating the balance between 
excitation and inhibition.  
In the central auditory system, a balance between excitation and inhibition is also 
critical for maintaining appropriate activities and functions of auditory neurons 
(Jastreboff and Sasaki, 1986; Chen and Jastreboff, 1995; Kenmochi and Eggermont, 
1997). An abnormal reduction in inhibition and/or increase in excitation can lead to 
epileptiform firing of action potentials in an auditory neuron. Such a type of neural firing 
can certainly affect an auditory perception (Guitton et al., 2003; Guitton and Puel, 2004).  
Functions of the hippocampus (Salvi et al., 2011) and the amygdala (De Ridder et 
al., 2006) also rely on the balance between excitation and inhibition. The main functions 
of the amygdala and hippocampus are emotion and memory, respectively. A proper 
balance between excitation and inhibition is required for these structures to function. A 
change to the balance can lead to differences in the functionality. An increase in activity 
in both structures is possible, which can be due to an increase in excitatory 
neurotransmission or a decrease in inhibitory neurotransmission (Chen et al., 2012). 
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Physiological studies have revealed that GABAB receptors are involved in the 
regulation of sound-driven responses in auditory structures (Faingold et al., 1989; 
Vaughan et al., 1996; Szcepanial and Moller, 1996). GABAB receptors in limbic 
structures are important for the activity of neurons, which are implicated in higher 
functions of the brain including stress and anxiety (Cryan and Kaupmann, 2005). 
Therefore, a change in GABAB receptors can affect auditory functions as well as stress 
and anxiety. 
1.7 Tinnitus 
 Tinnitus, i.e., ringing in the ear, is amongst the major types of hearing problems. 
An individual with tinnitus has a phantom sensation of sounds even when there is no 
stimulus present in the acoustic environment. Reported phantom sensations associated 
with tinnitus include ringing, buzzing, cricket-like sining, hissing, whistling, and 
humming (Canadian Academy of Audiology). Tinnitus affects a reported 360,000 
Canadians, of which 150,000 having their quality of life severely compromised 
(Canadian Academy of Audiology). 
 A study conducted by Axelsson and Ringdahi (1989) on 3,600 randomly selected 
adults in the general population revealed that 14.2% of the subjects had chronic tinnitus 
throughout the day. The remaining individuals experienced transient tinnitus. Also, males 
were more affected than females and the left ear was more affected than the right. Two 
point four percent of the people in the study group were affected to such a degree that 
their quality of life was severely affected. Among the affected aspects of life is the 
quality of sleep. They found a positive correlation between tinnitus severity and sleep 
disturbances.  
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1.7.1 Objective vs. subjective tinnitus 
1.7.1.1 Objective tinnitus  
 Objective tinnitus is a type of sensation caused by sounds generated within the 
peripheral auditory system (but not external environment) (Lockwood et al., 2002). There 
are three known causes of objective tinnitus. A tinnitus sensation with a pulsatile sound 
quality is usually caused by turbulent flow of blood in vessels near the cochlea 
(Weissman and Hirsch, 2000; Lockwood et al., 2002; Liyanage et al., 2006; Sonmez et 
al., 2007). The cause of this problem is linked to artery/vein malformations (or other 
vascular abnormalities), heart disease, high cardiac output, and other problems that may 
lead to turbulent blood flow (Lockwood et al., 2002). A tinnitus sensation with a clicking 
or low-pitched buzzing sound quality may be due to involuntary muscular contractions in 
the middle ear, specifically in the tensor tympani or stapedius muscle (Lockwood et al., 
2002; Abdul-Baqi, 2004; Howsam et al., 2005). This can be caused by a spasm that 
occurs in the stapedius or tensor tymapni muscle (Lockwood et al., 2002). A tinnitus 
sensation of environmental sound, may be due to irregular stimulation of outer hair cells. 
The cause of this is known to be spontaneous activation of acoustic emissions (Lockwood 
et al., 2002).  
1.7.1.2 Subjective tinnitus 
 Subjective tinnitus is sometimes interchangeably referred to as tinnitus 
(Lockwood et al., 2002). People with this form of tinnitus report hearing phantom sounds 
when there is no actual acoustic stimulation presented either in the external environment 
or within the body.  
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Figure 9: Molecular structures of sodium salicylate and acetylsalicylic acid (i.e. 
aspirin).  
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It is believed that subjective tinnitus is due to changes in the peripheral and/or 
central nervous system (Jastreboff, 1990; Lockwood et al., 2002; Moller, 2003; 
Rauschecker et al., 2010). Evidence supporting the central origin of tinnitus comes from 
the fact that blocking inputs to the central auditory system does not eliminate phantom 
sensations of sounds (House and Brackman, 1981; Barrs and Brackman, 1984; Berliner et 
al., 1992; Kaltenbach et al, 2005).  
 Subjective tinnitus can be induced by otologic, neurologic, infectious, or drug-
related factors. Otologic factors are associated with noise-induced hearing loss, 
presbycusis (i.e., age-dependent hearing loss), deafness, or any other cause of hearing 
loss. Neurological factors include head injury and multiple sclerosis. Infectious factors 
include otitis media, meningitis, syphilis, or any other infectious disease that can lead to 
hearing abnormalities. Drug-related factors include aminoglycoside antibiotics and 
various over-the-counter and prescription drugs that are used for treating inflammatory 
problems. Two examples of anti-inflammatory drugs are Aspirin and sodium salicylate 
(SS).  
1.8 Aspirin- and SS-induced tinnitus 
 Aspirin is available in North America as both an over-the-counter drug and a 
prescription drug. Prescription aspirin is generally used for relieving pain caused by more 
serious problems such as rheumatoid arthritis, osteoarthritis, and other rheumatologic 
conditions. In North America alone, about one hundred and twenty billion pills are 
prescribed each year (Warner and Mitchell, 2002). Effects of the drug are related to the 
inhibition of cyclooxygenase, which decreases prostaglandin production (Gong et al., 
2008). As a nonprescription drug, aspirin is used to relieve moderate pain from 
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headaches, menstrual cramps, toothaches, and muscle aches (NIH, 2016). The drug is 
capable of having such a widespread effect throughout the body because of its ability to 
reach systemic circulation (Rowland et al., 1972). After an oral dose is taken, the drug 
hydrolyzes to salicylic acids (Figure 9) and acetic acids (Rowland et al, 1972) of which 
the salicylic acid reaches peak plasma levels within 1-2 hours. The salicylic acid becomes 
widely distributed to many areas of the body including the central nervous system (Bayer 
Corp. USA).  
Salicylate itself has been administered to individuals to help treat various health 
problems such as advanced myelodysplastic syndrome, acute myelogenous, leukemia, 
and chronic lymphocytic leukemia. It is reported that the drug can reduce the incidence of 
cancer and enhance the survival rate of cancer patients (Klimek et al., 2012). 
 Despite the benefits, Aspirin and other salicylic drugs have side effects include 
nausea, vomiting, stomachache, and heartburn. It also causes hives, rash, difficulty in 
breathing, and swelling. The drugs also cause hearing problems including transient 
tinnitus and hearing loss. For Apirin, it is likely that its toxicity is produced by its 
metabolite salicylic acid. Therefore, it is sodium salicylate (SS) that is currently used by 
most of researchers in the study of ototoxic effects (e.g., tinnitus) of Aspirin and other 
salicylic drugs (Temple, 1978; Krause et al., 1992; Dargan et al., 2002).  
1.8.1 SS induces tinnitus in humans  
 Many studies have been conducted in which patients have been study to 
understand how SS can cause the sensation of tinnitus. Furthermore, Studies have been 
conducted to find the plasma level of SS required to induce tinnitus in human subjects to 
understand the toxic levels. An early study based on salicylate injections revealed that SS 
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at a blood concentration of 200mg/L can led to tinnitus in human subjects (Jagar and 
Always, 1946). When administered orally, salicylate can lead to deafness at a 
concentration of 250mg/L (Graham and Parker, 1948). Many subsequent studies also 
used oral administration of SS and found that tinnitus can be induced at  blood 
concentrations of below 100mgl/L to 250mg/L (Myers et al., 1965; McCabe and Day, 
1965; Mongan et al., 1973; Halla et al., 1991; Janssen et al., 2000).   
 1.8.2 Tinnitus-like behaviour induced by SS in animals   
 Behavioural paradigms have been developed to assess the induction of tinnitus-
like behaviour in animals. Some behavioural tests are based on conditioned suppression 
paradigms, which use water as a reward and foot-shocks as a punishment to shape animal 
behaviours. An animal is trained to obtain water reward through licking a drinking spout 
in the presence of a background sound and stop licking in the absence of the background 
sound. Failing to stop licking in the absence of the background sound following treatment 
of SS is interpreted as that the animal perceives a phantom sound in the absence of the 
background sound (i.e., showing a tinnitus behaviour). Using this behavioural paradigm, 
early studies found that SS applied systemically at a dosage of 300mg/kg could reliably 
induce tinnitus-like behavior in the rat (Jastreboff et al., 1988; Jastreboff and Sasaki, 
1994). Late studies indicate that the degree of tinnitus seems to be correlated with the 
dosage of SS within a range from 50 to 300mg/kg. Researchers also examined the blood 
salicylate concentration required for inducing tinnitus in the rat. Results closely resemble 
those from human subjects.  
1.8.3 Neurobiological changes caused by SS 
1.8.3.1 SS-induced changes in the auditory sensory organ  
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 In the peripheral auditory system, SS primarily affects outer hair cells in the 
cochlea. It is well known that outer hair cells can change their length in response to 
depolarization/hyperpolarization. Such an “electromotility” can enhance the sensitivity of 
the auditory sensory organ to sound stimulation. It has been found that SS can bind the 
motor protein prestin in the outer hair cells and reduce the electromotility of these cells 
(Shehata et al., 1991; Oliver et al., 2000; Chen et al., 2010). This can lead to a reduction 
in the output signal from the cochlea to the central nervous system. A reduction in 
cochlea output have been confirmed following systemic application (Cazals, 2000) as 
well as local application (in the cochlea) (Muller et al., 2009) of SS.  
1.8.3.2 SS-induced neurobiological changes in the central auditory system 
 Tinnitus-like behaviour has been reported in animals even after the auditory nerve 
fibers are disconnected from the brain (Berliner et al., 1992). This leads one to believe 
that there are central changes that are taking place. 
1.8.3.2.1 Effect of SS on the CN 
 The CN is the first auditory structure to receive information from the peripheral 
nervous system. Previous studies have shown the involvement of the CN in SS-induced 
tinnitus (Brozoski et al., 2002; Kaltenbach and Godfrey, 2008; Shore et al., 2007). 
Neurophysiological studies conducted using brain slice preparations have found that after 
SS application, the CN showed an increase in activity (Basta et al., 2008; Wei et al., 
2010). Another study based on manganese enhanced functional magnetic resonance 
imaging found that systemic application of SS cased an increase in activity in the DCN 
but no change in the VCN (Holt et al., 2010).  
1.8.3.2.2 Effect of SS on the IC  
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 The IC is a key structure involved in the processing of auditory information. 
Studies have been conducted on this auditory structure to find how it’s involved in 
tinnitus (Manabe et al., 1997; Bauer et al., 2000). An increase in the expression of an 
immediate early gene c-fos has been observed in the IC following application of SS, 
suggesting that neural activity in this structure can be increase by the drug (Wu et al., 
2003). A study based on manganese enhanced functional magnetic resonance imaging 
has supported that a systemic application of SS can increase the response in the IC, with 
the largest increase observed in the ICd (Holt et al., 2010). In vivo neurophysiological 
recordings confirmed a systemic application of SS can increase neural activities in the 
ICd and ICx (Jastreboff and Saskaki, 1986; Chen and Jastreboff, 1995; Manabe et al., 
1997). Recordings from brain slice preparations showed that SS has a local target in the 
IC (Basta and Ernst, 2000). This result has been supported by our own results obtained by 
using in vivo neurophysiological recording/neuropharmacological manipulations (Patel 
and Zhang, 2014). 
1.8.3.2.3 Effect of SS on the MGN  
 In spite of the importance of the MGN in auditory processing, not much attention 
has been paid to the role of this structure in the induction/generation of tinnitus. A study 
conducted by Basta and colleagues (2008) examined SS-induced changes in neural 
activity in the dorsal and ventral MGN using brain slice preparations. They found that SS 
enhanced activity in the MGN. In contrast to this finding, another brain slice study 
suggested that SS reduced firing of intrinsic action potentials in the MGN (Su et al., 
2012) studied the activity in the MGN after SS-application. 
1.8.3.2.4 Effect of SS on the AC 
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 The effect of SS on neurons in the AC has been extensively studied. Many studies 
have yieled comparable results. It has been found that SS increases spontaneous neural 
activity in a brain slice preparation. The increase in neural activity was dose-dependent 
(Basta et al., 2008). An in vivo study indicates that a systemic application of salicylate 
can increase sound-evoked neural activity in the AC (Yang et al., 2007). In another study, 
they used systemic and local application of SS. They found that sound-evoked neural 
activity increased, however, the spontaneous firing had reduced (Lu et al., 2011). 
1.8.3.3 Effects of SS on limbic structures 
1.8.3.3.1 Effect of SS on the amygdala  
 Recent studies have examined the effect SS on limbic structures, including the 
amygdala. Chen and colleagues (2014) used a rat model to study the effect of a systemic 
application of SS. Behavioural tests were conducted to ensure that a tinnitus-like 
behaviour was induced and in vivo recordings were conducted in the LaN of the 
amygdala. An SS-induced increase in neural activity was found. Neurochemical changes 
in the amygdala were also examined following a systemic application of salicylate. 
Immunocytochemical experiments revealed that expressions of arg3.1 and c-fos, which 
reflect the level of neural activity, were increased substantially in the structure following 
the drug application (Mahlke and Wallhausser-Franke, 2004). The largest change was 
found in the CeN. 
1.8.3.3.2 Effects of SS on the hippocampus  
 Studies have also examined the effect of SS on the hippocampus. In these studies, 
SS was applied systemically and behavioural tests were conducted to ensure that a 
tinnitus-like behavior was induced in experimental subjects. In vivo electrophysiological 
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recordings were then conducted in these animals. Results indicate that the drug causes an 
increase in activity in the hippocampus (Chen et al., 2014). An in vitro study conducted 
on the CA1 region of the hippocampus was also explored. Researchers found an increase 
in neuronal activation, following systemic application of salicylate (Gong et al., 2008).  
1.9 Possible central mechanisms underlying SS-induced tinnitus 
1.9.1 Tipping of balance between excitation and inhibition in auditory structures 
 It is believed by many researchers that tinnitus is dependent on 
neurophysiological changes in central auditory structures. These changes can include 
enhanced excitation and/or reduced inhibition, which can lead to excessive firing of 
action potential in the absence of external acoustic stimulation.  
Previous research has studied the effects of SS on the neural activity in the 
cochlea and the major auditory structures involved in tinnitus. From in vivo studies it was 
found that following a systemic application of SS, there was a decrease in sound-evoked 
activity in the cochlea (Muller et al., 2009). Further studies found SS caused a decrease in 
the electromotility of OHCs, which caused a decrease in signal output (Shehata et al., 
1991; Oliver et al., 2000; Chen et al., 2010). In contrast to the decrease in the output at 
the periphery, there is an increase in activity at the central structures. As mentioned in 
sections 1.8.3.2.1 – 1.8.3.2.4, there is generally an increase in activity of the auditory 
structures after SS-administration, with the exception of the MGN, which is indifferent 
(Basta and Ernst, 2000; Basta et al., 2008; Chen et al., 2014). Studying the structures in 
the ascending pathway could give better insight to this discrepancy.  
An increase in neural activity in central auditory structures is supported by 
functional imaging studies. Using the manganese enhanced magnetic resonance imaging 
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technique, Holt and colleagues (2010) found a widespread increase in neural activity in 
the central auditory system with the increase being highest in the DCN and ICd. In vitro 
neurophysiological studies also support that SS can enhance neural activities in central 
auditory structures. The recordings showed a reduction in GABA-mediated inhibition, 
which lead to an increase in excitatory potential (Wang et al, 2008; Gong et al., 2008). 
Studies also focused on the GABAergic inhibition to understand the increase in activity 
in the AC. They found that there was a reduction here as well (Sun et al., 2009; Lu et al., 
2011). However, there also exist inconclusive findings in which studies have shown a 
decrease or no significant change in activity (Basta and Ernst, 2004 Eggermont and 
Roberts, 2004; Ma et al., 2006). More studies are required to understand the molecular 
changes after tinnitus is induced (Knipper et al., 2009).  
An SS-induced increase in auditory neural activity could be due to effects of the 
drug on the abundance of neurotransmitter and/or neurotransmitter receptors in auditory 
neural structures. Butt and colleagues (2016) have found a decrease in level of GABAB 
receptors in the IC after a systemic application of SS. Zou and Shang (2012) studied the 
neurochemical changes that occur in GABAA receptors and GABA decarboxylase 
(GAD), which is an enzyme required for synthesizing GABA. They found a reduction in 
both levels in the CAS after the application of the SS. Similar studies have been done by 
Basta and colleagues (2000), which also found a reduction in the GABAA receptors after 
SS-application.  
Existing results have looked at how SS can cause changes in the expression of 
proteins. Some proteins are involved in contributing to both inhibitory and excitatory 
neurotransmission. These changes are most likely slower because they require the change 
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of cellular mechanisms. Researchers found a reduction in the mRNA expression of the 
GABAAα1 subunit. They also found a reduction in the mRNA expression of the enzyme 
GAD67 (Zou and Shang, 2012). In other studies an increase in the mRNA expression of 
NMDA receptor subunit 2A was found in the CN after SS administration (Hu et al., 
2014).  
1.9.2 Synchronization and bursting activity of auditory neurons 
 Other neurophysiological changes that may lead to a phantom sensation of sound 
include synchronization among activities generated by an ensemble of neurons. They also 
include enhanced bursting of action potential firing in auditory neurons. Both of these 
changes can be associated with reduction in inhibition. Following SS application, an 
increase in bursting activity was found in the IC (Chen and Jastreboff, 1995; Kwon et al., 
1999), while an increase in synchronization was seen in the auditory nerve (Cazals et al., 
1998). Studies based on electroencephalography and magnetoencephalograhy in human 
subjects supports an enhancement in synchronization in auditory cortical areas (Weisz et 
al., 2005; Schlee et al., 2009).  
1.9.3 Involvement of limbic structures 
 The induction/manifestation of tinnitus may be dependent on regulation by other 
neural structures. Inputs from these structures may influence auditory neurons and cause 
abnormalities in physiological functions of these neurons. The limbic system is likely 
involved in the regulation of auditory neural activities (Lockwood et al., 1998; Mahlke 
and Walhausser-Franke, 2004; Vlassenko et al., 2010; Kraus et al., 2012). Early evidence 
supporting the involvement of the limbic system includes that tinnitus can be modulated 
emotional distress (Jastreboff, 1990; Sullivan et al., 1998; Dobie, 2003). Such 
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observations are supported by recent studies showing strong associations between tinnitus 
and emotional stress, anxiety, and depression (Langguth, 2011).  
Anatomical studies indicate that the amygdala has direct connections with the 
MGN, while the hippocampus has indirect connections (See section 1.4). These 
connections likely serve as a gating mechanism that regulate the relay of neural signals 
from the MGN to the AC. Malfunction of this gating mechanism affect the relay of 
signals in the ascending auditory system (Leaver et al., 2011) which may contribute to the 
induction/manifestation of tinnitus. Such malfunction is likely important for the 
persistence of chronic tinnitus (Knipper et al., 2009; Galazyuk et al., 2012). 
 Knowledge about SS-induced changes in neurophysiological mechanisms and 
how these changes are dependent on neurochemical alterations in limbic structures is 
critical for understanding the involvement of these structures in the 
induction/manifestation of tinnitus. An important aspect of this knowledge is related to 
GABAergic neurotransmission. Researchers studied a molecule, i.e. GAD1, which is 
required to synthesize GABA. They found an increase, i.e. an upregulation in the level of 
this molecule (lm et al., 2007). It is equally importantly to study how SS affects the level 
of the GABAergic receptors in the limbic structures. It is especially important to study 
the level of the GABAB receptors. A GABAB receptor exists at both pre- and postsynaptic 
sites, the receptor possibly plays a major role in the regulation of excitation and inhibition 
in the limbic structures, which can consequently affect the level of activity in the central 
auditory system through limbic-thalamic projections. 
1.10 Research objectives and hypothesis  
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The specific objective of this thesis was to understand how systemic application 
of SS affects the level of GABAB receptors in the amygdala and hippocampus of a rat. I 
wanted to find whether the changes were localized to specific subdivisions of the 
amygdala and hippocampus. Based on previous findings, I hypothesized that the drug 
would cause an increase in the level of GABAB receptors in both structures. 
2 Experimental methods  
 Immunohistochemistry experiments were conducted to study the level of GABAB 
receptors in the rat’s auditory structures. Techniques used in this study were well 
established by previous members in my lab (Jamal et al., 2011; Jamal et al., 2012; Butt et 
al., 2016).  
2.1 Animal preparation  
Experiments were conducted using 250-350g male Wistar rats (Rattus norvegicus) 
obtained from Charles River Laboratories Inc. (St. Constant, QC). They were housed in 
the University of Windsor Animal Care Facility (with a noise level of 50-60 dB SPL) for 
at least a week before experiments were conducted. All procedures were done in 
accordance with the Canadian Council on Animal Care guidelines. 
Pairs of animals received either an intraperitoneal injection of SS (250mg/kg, i.p.) 
or an equivalent volume of physiological saline (PS). A survival period of three hours 
was given to allow SS-treated rats to develop a tinnitus-like behaviour (Jastreboff and 
Sasaki, 1994). Animals were euthanized with an overdose of sodium pentobarbital 
(120mg/kg, i.p.) and perfused with 200ml phosphate-buffered saline (PBS, 0.1M, pH 7.1) 
followed by 200ml paraformaldehyde (4% in PBS). Then the brains were extracted, 
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cryoprotected in 30% sucrose (in PBS), and sectioned along the coronal plane at 30µm 
using a cryostat (Leica Microsystems CM1050 S, Heidelberg, Germany). 
2.2 Immunohistochemical (IHC) experiments 
2.2.1 Experimental procedures 
An experiment was conducted by using tissue sections from the hippocampal and 
amygdala from a pair of PS- and SS-treated animals. For each structure (i.e., amygdala or 
hippocampus) of each animal, the sections were taken from the whole rostrocaudal extent 
of the structure at 300µm intervals. Sections from similar rostrocaudal locations of PS- 
and SS-treated animals were placed next to each other on a microscope slide (Figure 10). 
All the sections from a pair of animals were placed on four microscope slides. Each slide 
contained two cerebellar sections from PS- and SS- treated animals, respectively. These 
cerebellar sections were used as a positive control (Benke et al., 2002; Charles et al., 
2001; Ige et al., 2000). They were also used for providing references for normalization 
(Butt et al., 2016; also see Section 2.3). Throughout an entire immunohistochemical 
experiment, the four microscope slides were placed in the same slide jars to ensure that 
the same experimental conditions were applied to all the tissue sections. 
For each reaction, the tissues were first incubated for 22 hours in a primary 
antibody (see “Antibodies” section) in 0.1M PBS containing 0.05% Triton and 5% 
normal donkey serum. After three rinses (10 minute each) with 0.1M PBS, the tissues 
were incubated in a secondary antibody (see “Antibodies” section) in 0.1M PBS with 2% 
normal donkey serum for 2 hours. After another three rinses of 0.1M PBS (10 minutes 
each), tissues were incubated in ExtraAvidin-Peroxidase (1:400 in 0.1M PBS, Sigma-
Aldrich E2886, Oakville, ON) for 1.5 hours. The tissues were then rinsed in 0.1M PBS  
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Figure 10: Schematic diagram of a microscope slide showing the organization of 
brain slices. Gray area: naming system showing a sample naming. White area: showing 
where the slices were collected. PS CBM is the cerebellum from the PS-treated animal. 
SS CBM is the cerebellum from the SS-treated animal. PS 1-5 represents the limbic 
structures from the PS-treated animal. SS 1-5 represents the limbic structures from the 
SS-treated animal. The top row matches the bottom row in rostrocaudal location.  
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(10 minutes each) and stained with 3’3’ diaminobenzidine tetrahydrochloride in 0.1M-
phosphate buffer. Distilled water was used to stop the staining reaction. The tissue was 
then dehydrated using an ethanol gradient (60%, 70%, 95%, 100%, and 100%, 5 minutes 
per concentration) and cleared with two charges of histosol (10 minutes each). Finally, 
slides were coverslipped with the mounting medium, Permount (Fisher Scientific SP-500, 
Ottawa, ON). 
2.2.2 Antibodies  
The primary antibody against GABABR1 subunit was rabbit polyclonal 
GABABR1 antiserum (Santa Cruz Biotechnology R-300, 1:500). The primary antibody 
against GABABR2 subunit was guinea-pig polyclonal GABABR2 antiserum (Chemicon 
AB5394, 1:1000). 
The secondary antibody for probing GABABR1 subunit was biotinylated donkey 
anti-rabbit IgG (Jackson ImmnoResearch Laboratories 711-005-152, 1:400, Temecula, 
CA). The secondary antibody for probing GABABR2 subunit was biotinylated donkey 
anti-guinea pig IgG (Jackson ImmunoResearch Laboratories 706-065-148, 1:400, 
Burlington, ON). 
2.2.3 Positive and negative control experiments 
 Both negative and positive control experiments were conducted. Positive control 
experiments were conducted by using tissues from the cerebellum as previous studies 
have indicated that both GABABR1 and GABABR2 exist in this structure with the level 
being high in the molecular layer. My positive experiments revealed that antibodies for 
probing both GABABR1 and GABABR2 subunits were effective. 
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A negative control experiment was conducted using the same procedures as that 
described in section 2.2.1 with a primary antibody (against GABABR1 or GABABR2) or 
a secondary antibody (for probing GABABR1 and GABABR2) omitted. Negative control 
experiments revealed no labeling in either cell body or neuropil regions in the limbic and 
cerebellar tissues, indicating that the labeling in limbic structures in normal IHC 
experiments was specific.  
2.3 Data analysis  
Images of the sections subjected to IHC reactions were taken using a CTR 6500 
microscope and a DFC 425 digital camera (Leica Microsystems, Heidelberg, Germany). 
A piece of standard tissue was used to set light intensity and exposure. The same lighting 
condition was used across different imaging sessions to allow for quantitative comparison 
among images taken in different sessions. 
 Immunoreactivity was quatified using the LAS V4.5 software (Leica 
Microsystems, Heidelberg, Germany). An optic density (OD) was measured at each pixel 
to reflect the level of immunoreactivity. A mean OD was obtained for a target area or 
object (e.g., a cell body) by using the ODs obtained at all pixels within the target area or 
object. Immunoreactive cell bodies were identified using a threshold criterion. A 
threshold value was set for each individual slice as the mean OD of all the pixels in the 
neuropil region surrounding cell bodies minus three standard deviations of all the ODs at 
these pixels. For the amygdala, an additional length criterion was used. Only objects that 
passed the threshold criterion and with their longest axes in a range between 4 and 26 
micrometer were included. Visual examination was also used to help identify the 
immunoreactive cell bodies.  
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 To compare the level of immunoreactivity in a target area or a group of labeled 
neurons between a pair of SS- and PS-treated animals, the mean OD value of the target 
area or each neuron in the group was normalized using the OD values from the molecular 
layer and the white matter of the cerebellum. The level of GABAB receptors in the 
cerebellum is not affected by the systemic application of SS (Butt et al., 2016) 
IRN = (ODLS – ODWM)/(ODMol – ODWM) 
where IRN is a normalized level of immunoreactivity of a hippocampal or amygdaloid 
area or cell body. ODLS, ODWM, ODMol are the mean OD values of a cell body/area in the 
limbic structure of interest (i.e. hippocampus or amygdala), the white matter of the 
hippocampus, and the molecular layer of the cerebellum, respectively. The OD values 
from the cerebellar regions were used in normalization as our previous study indicated 
that these values are not affected by systemic application of SS (Figure 12; also see Butt 
et al., 2016). 
2.3.1 Statistical analysis 
 All bar charts represent the mean OD ± standard deviation. Based on the specific 
data sets, a two-tail t-test or a two-way ANOVA was conducted. A level of p < 0.05 was 
considered to be statistically significant.  
3 Results 
3.1 Control experiments and the effect of SS on GABAB receptors in the cerebellum 
 Positive and negative control experiments were conducted to ensure the 
effectiveness of antibodies and the reliability of IHC results. To ensure that antibodies 
were effective in probing the GABABR1 or GABABR2 subunits, positive control 
experiments were conducted by using tissues from the cerebellum as both subunits exist  
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Figure 11: Positive and negative control using cerebellum tissue. M: molecular layer, 
G: granular layer, W: white matter. Top panel shows a positive control by showing the 
immunolabeling in the cerebellum by probing both GABABR1 and GABABR2. Middle 
panel shows a negative control by omitting the primary antibody for GABABR1 and 
GABABR2. Bottom panel shows a negative control by omitting the secondary antibody 
for GABABR1 and GABABR2. Scale bar: 100µm.  
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in this brain structure (Jamal et al., 2012). In all the six pairs of animals examined in this 
study, I conducted IHC experiments against the GABABR1 and GABABR2 subunits 
using pairs of cerebellar tissues from the PS- and SS-treated animals. These experiments 
revealed clearly labeled cells including large Purkinje cells (Figure 11). The neuropil 
regions surrounding these cells were also labeled. These results suggest that the 
antibodies used in our study were effective.  
Negative control experiments were conducted by using cerebellar tissue from one 
pair (i.e. one case) of animals. These experiments were conducted by omitting either the 
primary or secondary antibody for probing the GABABR1 or GABABR2 subunit while all 
the other experimental procedures were kept exactly the same as those described in the 
“immunohistochemical (IHC) experiments” section. The experiments revealed very faint 
labeling of cell bodies and surrounding neuropil regions, suggesting that the antibodies 
used in the present study was specific in labeling the GABABR1 or GABABR2 subunits 
(Figure 11).  
 The level of labeling in the molecular layer of the cerebellum was quantified for 
both the GABABR1 and GABABR2 subunits in six cases. Results revealed that SS did not 
affect the level of either of the GABAB receptor subunits (Figure 12). The quantification 
showed no significant difference between the two treatments (two-tail T-test; 0.158; 6). 
These results agree with that revealed by a previous study from our lab (Butt et al., 2016). 
The lack of the effect of SS on the level of receptor subunits in the molecular layer of the 
cerebellum suggest that any changes observed in the amygdala and hippocampus were 
specific to these limbic structures. 
3.2 Effect of SS on the level of GABAB receptor subunits in the amygdala  
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Figure 12: No change in molecular layer of cerebellum in SS-treated animals. (A) 
low magnification images of cerebellum from PS- and SS-treated animals probed with 
GABABR1 and GABABR2. (B) group results showing little change between the 
molecular layers of PS- and SS-treated in both subunits. Results are from six pairs of 
animals. Change is not statistically significant (two-tail T-test (5); t = 0.8296; p = 0.158). 
Scale bar: 100µm.   
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3.2.1 Normative immunoreactivities against GABABR1 and GABABR2 in the 
amygdala 
 Results from six PS- treated animals were examined to understand the normative 
immunoreactivities against GABABR1 and GABABR2. For both subunits, an  
immunoreactivity was observed throughout the entire structure. The level of labeling was 
reduced from the rostral to the caudal part of the structure. A closer examination revealed 
a similar level of labeling in BLA, BMA, and LA, and a higher level of labeling in the 
CeN. This was consistent throughout the rostrocaudal extent of the structure.   
3.2.2 Effect of SS on the overall level of receptor subunits in the amygdala 
The effect of SS on the level of GABABR1 and GABABR2 in amygdala was 
studied in six pairs of PS- and SS-treated animals. Results were quantified in all six cases. 
For each animal, ten tissue sections containing the amygdala and one section containing 
the cerebellum were used in IHC experiments.  
As shown by an example in Figure 13, levels of immunoreactivity were similar 
between cerebellum tissues obtained from the PS- and SS-treated animals for both the 
GABABR1 and GABABR2 (Figure 13 top row). In contrast, the level of labeling in the 
amygdala was higher in the SS-treated than the PS-treated animal for both subunits 
(Figure 13 middle and bottom rows). 
The level of labeling was compared between PS- and SS-treated animals over the 
rostrocaudal extent of the amygdala. For both the GABABR1 and GABABR2 subunits, SS 
resulted in an overall increase in immunolabeling throughout the entire extent (Figure 14 
and Figure 15). The increase tended to be larger in the caudal than the rostral part of the 
structure.  
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Figure 13: Change in overall mean OD of SS-treated animals in the amygdala. (A) 
shows immunolabeling against GABABR1 subunit and (B) shows the immunolabeling 
against the GABABR2 subunit in the cerebellum (top panel) and amygdala (bottom panel) 
in both PS- and SS-treated animals. Scale bar: 300µm.  
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Figure 14: Immunolabeling against GABABR1 in the rostrocaudal slices of the 
amygdala. Major subdivisions are outlined. Scale bar: 300µm. 
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Figure 15: Immunolabeling against GABABR2 in the rostrocaudal slices of the 
amygdala. Major subdivisions are outlined. Scale bar: 300µm.  
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Figure 16: Group results from IHC experiments showing overall changes in 
normalized OD values of the amygdala in both GABABR1 and GABABR2 subunits. 
Results were combined from the OD of the major subdivisions and then normalized the 
cerebellum from the specific IHC experiment. Results are from six pairs of animals. The 
change is statistically significant for both GABABR1 (two-tail T-test (22); t=3.5524 
p<0.005) and GABABR2 (two-tail T-test (22); t=4.8263; p<0.001).  
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A weighted average OD was used to evaluate the overall level of 
immunoreactivity against a receptor subunit (GABABR1 or GABABR2) in the amygdala 
of an animal. Results from 3 pairs of animals reveled that SS produced an overall 
increase in level of both receptor subunits (Figure 16), with the increase being  
statistically significant for both GABABR1 (two-tail T-test; p<0.005; n=6) and 
GABABR2 (two-tail T-test; p<0.001; n=6).  
3.2.3 Effects of SS in major amygdaloid subdivisions  
 Six cases were analyzed to study the effect off SS on the GABABR1 and 
GABABR2 subunits in the four major subdivisions of the amygdala. A weighted average  
OD was obtained for each subdivision of the structure. For the GABABR1 subunit, results 
from 6 pairs of PS- and SS-treated animals indicate that the  increase was similar among 
the subdivisions including the BLA, BMA, and CeN, and slightly larger in LaN (Figure 
17 and Figure 19a). The rostral slices became more area specific, showing a larger 
increase in labeling in the LaN, compared to other subdivisions.  The increase in all the 
subdivisions was statistically significant (two-way ANOVA; p<0.001; n=6).  
 The effect of SS on the GABABR2 subunit was also evaluated in the four major 
amygdaloid subdivisions. Results indicate that the level of the receptor subunit was 
increased in all the subdivisions. The SS-induced increase was similar among the BLA, 
BMA, and CeN, but some how larger in the LaN (Figure 18 and Figure 19b). The 
increase in all the subdivisions were statistically significant (two-way ANOVA; p<0.05; 
n=6).  
3.2.4 The effect of SS on immunoreactivities in cell bodies   
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Figure 17: High magnification images of the major subdivisions of the amygdala 
labeled against GABABR1. Low magnification images show the different subdivisions 
for the PS and SS-treated animals. Corresponding high magnification images are from the 
specific subdivisions. Low magnification image scale bar: 300µm. High magnification 
image scale bar: 25µm.  
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Figure 18: High magnification images of the major subdivisions of the amygdala 
labeled against GABABR2. Low magnification images show the different subdivisions 
for the PS and SS-treated animals. Corresponding high magnification images are from the 
specific subdivisions. Low magnification image scale bar: 300µm. High magnification 
image scale bar: 25µm.  
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Figure 19: Group results from IHC experiments showing overall changes in 
normalized OD values of the major subdivisions of the amygdala in both GABABR1 
and GABABR2 subunits. Results were normalized against the cerebellum from the 
specific IHC experiment. Results are statistically significant for both GABABR1 two-way 
ANOVA (22); p<0.001; n=6) and GABABR2 (two-way ANOVA (22); p<0.05; n=6).  
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Figure 20: High magnification images showing immunolabeled cells against 
GABABR1 and GABABR2 in the four major subdivisions of the amygdala. Both PS- 
and SS-treated labeled against GABABR1 and GABABR2 in all subdivisions including 
the (A) BLA, (B) BMA, (C) CeN, and (D) LaN. Scale bar: 10µm.  
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 For both the GABABR1 and GABABR1 subunits, the effect of SS on the level of 
immunoreactivity was studied in cellular regions in six cases. High magnification images 
indicate that the overall increase in the level of immunoreactivity against the receptor 
subunits was highly dependent on the increase in cell body regions. Further observations 
indicated a difference in the pattern of labeling between the GABABR1 and GABABR2 
subunit (Figure 20). While the labeling by the GABABR1 antibody was generally 
stronger in the periphery than the center of a cell body, the labeling by the GABABR2 
antibody was typically stronger in the center than the periphery of a cell body. This was 
consistent in both PS- and SS-treated animals. 
A mean OD value was obtained for each cell body (See Section 2.3 for method). 
The number of immunoreactive cell bodies and the distribution of OD values of 
immunoreactive cell bodies were compared in six pairs of PS- and SS-treated animals. 
For GABABR1 subunit, there was a significant increase in the mean OD of the SS-treated 
animals in all subdivisions (two-way ANOVA; p<0.01; n=6). Compared with that of a 
PS-treated animal, the distribution of the normalized OD of an SS-treated animal was 
shifted rightward, indicating an increase in the level of labeling in the cell bodies of the 
amygdaloidal cells (Figure 21 and Figure 22a). This change was observed in all four 
subdivisions, with the largest change being in the LaN. The density of labeled cells, 
measured as number per square millimeter, was also increased in the SS-treated animal 
(Figure 22b). This increase was significant (two-way ANOVA; p<0.05; n=6) 
The effect of SS on GABABR2-immunoreactive cell bodies was similar that on 
GABABR1-immunoreactive cell bodies. The drug caused a rightward shift to the 
distribution of the OD of labeled cell bodies, indicating the drug increased the level of  
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Figure 21: Histograms showing the number of neurons within a specific normalized 
mean OD in GABABR1 immunolabeled cells in the amygdala. Black bars represent 
PS-treated animals and white bars represent SS-treated animals.  
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Figure 22: Group results from IHC experiments showing changes in (A) normalized 
OD values of the cells bodies in each subunit and (B) cell density of GABABR1 
immunolabeled cells in the amygdala. (A) Results were normalized against the 
cerebellum from the specific IHC experiment. Results were obtained from six pairs of 
animals and are statistically significant (two-way ANOVA (22); p<0.01) (B) Results 
were measured as cells per square millimeter. Results were obtained from six pairs of 
animals and are statistically significant (two-way ANOVA (22); p<0.05).  
 
 
 
 
 
 
 
 
 
 68 
 
 
Figure 23: Histograms showing the number of neurons within a specific normalized 
mean OD in GABABR2 immunolabeled cells in the amygdala. Black bars represent 
PS-treated animals and white bars represent SS-treated animals.  
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Figure 24: Group results from IHC experiments showing changes in (A) normalized 
OD values of the cells bodies in each subunit and (B) cell density of GABABR2 
immunolabeled cells in the amygdala. (A) Results were normalized against the 
cerebellum from the specific IHC experiment. Results were obtained from six pairs of 
animals and are statistically significant (two-way ANOVA (22); p<0.001). (B) Results 
were measured as cells per square millimeter. Results were obtained from six pairs of 
animals and are statistically significant (two-way ANOVA (22); p<0.05).   
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GABABR2 subunit in all the amygdaloid subdivisions (Figure 23). The increase was the 
highest in the LaN. Group results revealed a significant increase in all the mean OD of all 
subdivisions (two-way ANOVA; p<0.001; n=6), along with a significant increase in the 
number of labeled cells per square millimeter (two-way ANOVA; p<0.05; n=6) (Figure 
24).  
3.3 Effect of SS on the level of GABAB receptor subunits in the hippocampus  
3.3.1 Normative immunoreactivities against GABABR1 and GABABR2 in the 
hippocampus  
Results from six PS-treated animals were examined to understand the normative 
immunoreactivities against GABABR1 and GABABR2. For both subunits, an 
immunoreactivity was observed throughout the entire structure. The subdivisions were 
not found consistently throughout the structure: the SUB appeared only in caudal slices, 
while all other subdivisions were found throughout the whole rostrocaudal extent. The 
level of labeling was reduced from the rostral to the caudal part of the structure.  A closer 
examination of the subdivisions showed a similar level of labeling in CA1-CA3, DG, and 
SUBd and a higher level of labeling in the SUBv. In caudal slices, the DG showed an 
area difference: the dorsal portion showed a higher labeling than the ventral portion.  
3.3.2 Effect of SS on the overall level of receptor subunits in the hippocampus  
 IHC experiments were conducted using tissues from the hippocampus in six pairs 
of PS- and SS-treated animals. Overall level of labeling (i.e., all the cell bodies and 
surrounding neuropil regions combined) in the entire hippocampus were quantified in 
these six cases.  
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Figure 25: Change in overall mean OD of SS-treated animals in the hippocampus. 
(A) shows immunolabeling against GABABR1 subunit and (B) shows the 
immunolabeling against the GABABR2 subunit in the cerebellum (top panel) and 
hippocampus (bottom panel) in both PS- and SS-treated animals. Scale bar: 300µm.  
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As shown by an example in Figure 25, there was no difference in the level of 
labeling between the cerebellar sections from PS- and SS-treated animals for both 
subunits (Figure 25). In contrast, a change in the level of labeling was observed in certain 
areas of the hippocampus for both the GABABR1 and GABABR2 subunits (Figure 25). 
The two pairs of hippocampal sections in Figure 25 show immunoreactivities against 
GABABR1 and GABABR2, respectively. Each pair of sections was from a pair of PS- and  
SS-treated animals at the mid portion of the rostrocaudal extent of the hippocampus. 
Overall, the level of the receptor subunits was increased in the section from the SS-
treated animal. 
The effect of SS on the level of the GABABR1 and GABABR2 subunits was 
examined over the entire rostrocaudal extent of the hippocampus (Figure 26 and Figure 
27). Overall, an increase in immunoreactivity against the GABABR1 subunit was 
observed in caudal sections in SS-treated animals. In contrast, a reduction in 
immunoreactivity against GABABR1 subunit was observed in rostral sections in SS-
treated animals. 
The GABABR2 subunit showed a very similar spatial pattern of change to that of 
change in GABABR1 throughout the rostrocaudal extent of the hippocampus (Figure 27) 
Overall, an increase in the immunoreactivity against GABABR2 was observed in caudal 
sections and a reduction in immunoreactivity was observed in rostral sections in SS-
treated animals.  
For each receptor subunit, a weighted average OD was calculated for each animal 
by using the measurements from all the hippocampal regions in the entire set of 12 
sections (Figure 28). Group results from six pairs of PS- and SS-treated animals  
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Figure 26: Immunolabeling against GABABR1 in the rostrocaudal slices of the 
hippocampus. Hippocampal region is outlined. Scale bar: 300µm. 
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Figure 27: Immunolabeling against GABABR2 in the rostrocaudal slices of the 
hippocampus. Hippocampal regions is outlined. Scale bar: 300µm. 
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Figure 28: Group results from IHC experiments showing overall changes in 
normalized OD values of the hippocampus in both GABABR1 and GABABR2 
subunits. Results were combined from the OD of the major subdivisions and then 
normalized the cerebellum from the specific IHC experiment. Results were obtained from 
six pairs of animals and statistically significant in both GABABR1 (two-tail T-test (35); 
t=3.1781; p<0.05) and GABABR2 (two-tail T-test (35); t=3.6048; p<0.05).  
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Figure 29A: High magnification images of the CA1-CA3 subdivisions of the 
hippocampus labeled against GABABR1. Low magnification images show the different 
subdivisions for the PS and SS-treated animals. Corresponding high magnification 
images are from the specific subdivisions. Low magnification image scale bar: 300µm. 
High magnification image scale bar: 25µm.  
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Figure 29B: High magnification images of the DG, SUBv, and SUBd subdivisions of 
the hippocampus labeled against GABABR1. Low magnification images show the 
different subdivisions for the PS and SS-treated animals. Corresponding high 
magnification images are from the specific subdivisions. Low magnification image scale 
bar: 300µm. High magnification image scale bar: 25µm.  
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indicate that SS increased the level of receptor subunits in the hippocampus (Figure 28). 
This increase was statistically significant in both GABABR1 (two-tail T-test; p<0.05; 
n=6) and GABABR2 (two-tail T-test; p<0.05; n=6).  
3.3.3 The effect of SS in major hippocampal subdivisions 
Levels of immunoreactivities against the GABABR1 and GABABR2 subunits in 6 
main subdivisions of the hippocampus were quantified in three cases. A weighted average  
OD was obtained for each subdivision for both GABABR1 and GABABR2 subunits. For 
GABABR1 the largest increase was observed in the CA1-CA2 regions. Similar changes 
were observed in CA3, DG, SUBd, and SUBv (Figure 29 and Figure 31a). For the CA3 
and DG subdivisions, there exist a rostrocaudal area difference in which an increase in 
OD is obsereved in the caudal slices and a decrease is observed in the rostral slices. 
Overall, the increase of mean OD in all subdivisons was not statistically significant (two-
way ANOVA; 0.11541; n=6).  
 The effect of SS on GABABR2 was also quantified in six cases examining all six 
subdivisions. Results indicated an increase in level of labeling in all subdivisions. Similar 
increase was observed in CA2, DG, and SUBd, but larger in CA1, CA3, and SUBv 
(Figure 30 and Figure 31b). Similar to the GABABR1 subunit, CA1 and DG showed an 
increase in mean OD in caudal slices and a decrease in rostral slices in SS-treated 
animals. Overall the increase was not statistically significant in all subdivisions  (two-
way ANOVA; p <0.05; n=6).  
3.3.4 The effect of SS on immunoreactivities in cell bodies   
 Both GABABR1 and GABABR2 subunits were studied to understand the effect of 
SS on the level of immunoreactivity in cellular regions in six cases. High magnification  
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Figure 30A: High magnification images of the CA1-CA3 subdivisions of the 
hippocampus labeled against GABABR2. Low magnification images show the different 
subdivisions for the PS and SS-treated animals. Corresponding high magnification 
images are from the specific subdivisions. Low magnification image scale bar: 300µm. 
High magnification image scale bar: 25µm.  
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Figure 30B: High magnification images of the DG, SUBv, and SUBd subdivisions of 
the hippocampus labeled against GABABR2. Low magnification images show the 
different subdivisions for the PS and SS-treated animals. Corresponding high 
magnification images are from the specific subdivisions. Low magnification image scale 
bar: 300µm. High magnification image scale bar: 25µm.  
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Figure 31: Group results from IHC experiments showing overall changes in 
normalized OD values of the major subdivisions of the hippocampus in both 
GABABR1 and GABABR2 subunits. Results were normalized against the cerebellum 
from the specific IHC experiment. Results were obtained from six pairs of animals. 
Results were not statistically significant for GABABR1 (two-way ANOVA (35); 0.11541) 
and statistically significant for GABABR2 (two-way ANOVA (35); p <0.05).  
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Figure 32: High magnification images showing immunolabeled cells against 
GABABR1 and GABABR2 in the six major subdivisions of the hippocampus. Both 
PS- and SS-treated animals were labeled against GABABR1 and GABABR2 in the (A) 
CA1, (B) CA2, (C) CA3, (D) DG, (E) SUBd, and (F) SUBv. Scale bar: 10µm.  
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Figure 33: Histograms showing the number of neurons within a specific normalized 
mean OD in GABABR1 immunolabeled cells in the hippocampus. Black bars 
represent PS-treated animals and white bars represent SS-treated animals.  
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images revealed a difference in the cellular distributions of the GABABR1 and 
GABABR2 subunits in hippocampal cells (Figure 32). While immunoreactivity against 
GABABR1 subunit was typically stronger in the surrounding area than the center of a cell 
body, the immunoreactivity against the GABABR2 subunit was typically stronger in the 
center then the surrounding area of a cell. This difference was observed throughout the 
structures in both PS- and SS-treated animals. 
In six pairs of PS- and SS-treated animals, the level of labeling was evaluated in 
GABABR1-immunoreactive cell bodies in the hippocampus using mean OD values 
(Figure 33). For each subdivision, there was a rightward shift in the distribution of mean  
OD in an SS-treated animal, indicating an overall increase in the level of GABABR1 in 
the SS-treated animals. Group results supports that the drug caused an increase in the 
level of labeling in the GABABR1 subunit. The increase was highest in SUBv subdivision 
(Figure 34a). This change for all subdivisions was statistically significant (two-way 
ANOVA; p<0.01; n=6). Group results also indicated a tendency of increase in the 
number of labeled cells per square millimeter (Figure 34b). However, this increase was 
not statistically significant in all subdivisions (two-way ANOVA; p=0.22588; n=6).   
 Similar analysis was conducted for cell bodies showing immunoreactivities 
against the GABABR2 subunit. The distribution of ODs of labeled cells was shifted 
rightward in the SS-treated animal of each of the 6 pairs of animals (Figure 35). Group 
results supports that the drug caused an increase in the mean OD of labeled cells in all 
subdivisions of the hippocampus, with the largest change being in the SUBv (Figure 36a). 
These results were statistically significant (two-way ANOVA; p<0.01; n=6). Group 
results also indicated a tendency of increase in the number of labeled cell bodies per  
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Figure 34: Group results from IHC experiments showing changes in (A) normalized 
OD values of the cells bodies in each subunit and (B) cell density of GABABR1 
immunolabeled cells in the hippocampus. (A) Results were normalized against the 
cerebellum from the specific IHC experiment. Results were obtained from six pairs of 
animals and were statistically significant (two-way ANOVA (35); p<0.01). (B) Results 
were measured as cells per square millimeter. Results were obtained from six pairs of 
animals and were not statistically significant (two-way ANOVA (35); p=0.22588).   
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Figure 35: Histograms showing the number of neurons within a specific normalized 
mean OD in GABABR2 immunolabeled cells in the hippocampus. Black bars 
represent PS-treated animals and white bars represent SS-treated animals.  
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Figure 36: Group results from IHC experiments showing changes in (A) normalized 
OD values of the cells bodies in each subunit and (B) cell density of GABABR1 
immunolabeled cells in the hippocampus. (A) Results were normalized against the 
cerebellum from the specific IHC experiment. Results were obtained from six pairs of 
animals and were statistically significant (two-way ANOVA (35); p<0.01). (B) Results 
were measured as cells per square millimeter. Results were obtained from six pairs of 
animals and were not statistically significant (two-way ANOVA (35); 0.08328).   
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square millimeter (Figure 36b). This increase was not statistically significant (two-way 
ANOVA; 0.08328; n=6).  
4 Discussion   
 My results revealed that a systemic application of SS caused an increase in the 
level of GABABR1 and GABABR2 subunits in the amygdala and the hippocampus. The 
increase was generally larger in the amygdala than in the hippocampus. A regional  
difference in the level of increase was seen in the amygdala. For both subunits, the 
percent increase was the greatest in the LaN and smallest in the BMA. A moderate 
increase was seen in the BLA and CeN. Apparent area differences existed in the 
hippocampus. Overall, for GABABR1 subunit showed a larger percentage increase in the 
weighted average OD of CA1-CA2 regions, whereas a moderate increase was observed in 
CA3, DG, SUBd, and SUBv. The GABABR2 subunit showed a larger percentage 
increase in the weighted average OD of CA1, CA3, and SUBv, whereas a moderate 
increase was observed in the CA2, DG, and SUBd.  
4.1 Technical considerations 
 Both positive and negative control experiments were conducted to ensure the 
effectiveness of experimental procedures and reliability of results from the limbic 
structures (Figure 11). Each of the immunohistochemical experiments done to probe 
GABABR1 or GABABR2 subunit in a pair of PS- and SS-treated animals consisted of a 
pair of cerebellar sections from the same pair of animals. While the experiments revealed 
an increase in the level of immunolabeling in the limbic structures, they did not reveal a 
change in the cerebellum. This indicates that changes in the level of GABABR1 and 
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GABABR2 subunits observed in the limbic structures were due to the drug and not other 
possible factors.  
 An SS injection of 250mg/kg was used to reliably induce tinnitus in the SS-treated 
animals. This amount is relatively high in comparison to the amount humans are regularly 
exposed to. Therefore, a direct comparison of tinnitus between humans and experimental 
animals cannot be made. The amount was used to ensure that tinnitus had been subjected 
in the animals, so that neurochemical changes could be studied. Understanding of such 
changes can lead to possible future treatments.  
 The current study examined GABABR1 and GABABR2 subunits separately. 
Results can’t be used to make a definite conclusion about the effect of SS on functional 
GABAB receptors. However, parallel changes in the level of immunoreactivity between 
the two receptor subunits strongly suggest that the level of functional GABAB receptors 
were changed by the drug. Existing results indicate that GABABR1 is synthesized in the 
endoplasmic reticulum and contains a retention signal that does not allow it to travel to 
the plasma membrane. GABABR2 is required to bind to the GABABR1 subunit, which 
leads to masking of the retention signal and consequently a functional GABAB receptor 
can be formed in the plasma membrane (Pin et al., 2004). Immunofluorescent double 
labeling experiments should be conducted to make a definite conclusion regarding the 
effect of SS on the level functional GABAB receptors in limbic structures. 
4.2 Possible neurophysiological consequences of an increase in the level of 
GABABR1 and GABABR2 
An increase in the level of GABAB receptors can lead to different 
neurophysiological consequences depending on whether these receptors are distributed 
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pre- or postsynaptically. Upon activation of postsynaptic GABAB receptors a prolonged 
inhibition occurs. After GABA binds to the receptor, it leads to the dissociation of the βγ- 
subunit from the α-subunit in the G-protein. This subunit activates GIRK, which is 
activated and allowed K+ to leave the cell, thereby hyperpolarizing the cell membrane 
(Luscher et al., 1997; Ulrich and Bettler, 2007). By increasing the level of postsynaptic 
GABAB receptors, it is possible to decrease the neural activity due to an increase in 
inhibitory neurotransmission. 
 Presynaptic GABAB receptors function by inhibiting the release of GABA or 
glutamate neurotransmitters (Ma et al., 2002; Kornau, 2006). Upon GABA binding, the 
βγ-subunit dissociates from the α-subunit. It leads to the modification of voltage-gated 
Ca2+ channels. This causes a reduction in Ca2+ influx, which leads to a decrease in 
neurotransmitter release (Herlitze et al., 1996; Ikeda, 1996). By increasing the level of 
presynaptic GABAB receptors, there is possibility of either an increase or decrease in 
neural activity depending on which neurotransmitter is regulated. Regulation of glutamate 
can lead to a decrease in neural activity as this means a reduction in excitatory 
neurotransmission. Regulation of GABA can lead to an increase in neural activity as this 
means a reduction in inhibitory neurotransmission. 
4.3 The effect of SS on the amygdala and hippocampus  
4.3.1 Neural activity vs. the level of GABAB receptors 
 Previous studies have indicated that SS can lead to an increase in neural activity 
in the amygdala and hippocampus (Chen et al., 2014). The present study focused on 
neurochemical changes following a systemic application of SS and revealed an increase 
in the level of GABAB receptors in the amygdala and hippocampus. It is highly likely that 
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it was presynaptic GABAB receptors that were increased in the present study. Such 
presynaptic GABAB receptors serve as auto-receptors and regulate the release of GABA. 
This regulation can certainly enhance neural responses as revealed by the previous 
physiological study conducted by Chen and colleagues. It should be noted that 
GABAergic auto-receptors have been found in both the amygdala and hippocampus 
(Yamada et al., 1999; Ariwodola and Weiner, 2004).  
4.3.2 Area dependence in the change of level of GABAB receptors 
The amygdala showed a larger change in the level of GABAB receptors than the 
hippocampus. There is a logical explanations for such findings. The amygdala has direct 
connections from the auditory structures, i.e. projections from the MGN, whereas the 
hippocampus is indirectly connected to the auditory structures by projections to and from 
the amygdala (Kraus and Canlon, 2012). The MGN sends direct projections to the LaN of 
the amygdala (Graybiel, 1972; Aitkin, 1986) and the AC sends indirect projections to the 
LaN (Kraus and Canlon, 2012).  The LaN then sends projections to the BLA, which 
sends direct projections to the CA1, CA3 and indirect connections to the SUB (Kraus and 
Canlon, 2012). 
 Projections towards the auditory system include the CA1 and SUB, which send 
projections to the LaN, BMA, and BLA. The BLA then sends direct projections to the IC 
in the auditory pathway (Sah et al., 2003; LeDoux, 2007; Kraus and Canlon, 2012).   
 The current study found an area difference in which the largest increase in 
GABAB receptors was found in the LaN in the amygdala and the SUBv in the 
hippocampus. The involvement of LaN and SUBv in receiving and sending information 
from/to the CAS, respectively, is quite important. LaN receives projections from the 
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MGN, while SUB sends information towards the amygdala to relay it back to the CAS 
(Kraus and Canlon, 2012).  However, further studies are required to understand the neural 
activity in each subdivision and how it relates to GABAB receptors. This would allow to 
further speculating as to what activity changes would be caused in the CAS due to limbic 
structures.   
4.4. Effects of SS on the level of GABAB receptors in limbic structures vs. major 
auditory structures 
 Previous studies have indicated that systemic application causes a change in 
neural activity in both the central auditory system (House and Brackman, 1981; Barrs and 
Brackman, 1984; Berliner et al., 1992; Kaltenbach et al., 2005) and the limbic system 
(Mahlke and Wallhausser-Franke, 2004; Gong et al., 2008; Chen et al., 2014). 
Specifically, both these systems show an increase in neural activity following the 
application of the drug.  
A neurochemical study (Butt et al., 2016) revealed that SS reduced the level of 
GABAB receptors in an auditory structure, the IC. In contrast, the present study found 
that the drug caused an increase in the level of GABAB receptors in limbic structures. 
Therefore, a seeming discrepancy exists between the drug effects on the level of GABAB 
receptors in the IC and limbic structures, inspte of similar increases in the physiological 
activity in these structures.  
It is speculated that in the IC SS reduced postsynaptic GABAB receptors and/or 
presynaptic GABAB receptors on glutamatergic axon terminals. A reduction in these 
GABAB receptors would enhance the release of glutamate from presynaptic terminal or 
reduce the inhibitory postsynaptic potentials mediated by the postsynaptic GABAergic 
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neurons. Consequently, this could enhance the overall activity in the IC. In the limbic 
structures, it is possible that the drug increase presynaptic GABAB receptors on 
GABAergic axon terminals. Such an increase could reduce the release of GABA, leading 
to a decrease in inhibition and an increase in activity.  
4.5 SS-induced change in the level of GABAB receptors: Implications for higher 
brain functions 
4.5.1 Tinnitus 
 SS-induced tinnitus leads to changes in neural activity in the limbic structures 
(Chen et al., 2012) as well as central auditory structures (; House and Brackman, 1981; 
Barrs and Brackman, 1984; Berliner et al., 1992). Previous studies have suggested that SS 
can affect neurotransmitter receptors and ion channels (Basta et al., 2000; Basta and 
Ernst, 2004). The present study viewed the neurochemical changes in GABAB receptors 
caused by SS in limbic structures. The drug showed to cause an increase in the GABAB 
receptors, which can lead to a change in neural activity, thereby tipping the balance of 
excitation and inhibition in the limbic structures.  
 Previous studies have found an increase in neural activity in the limbic structures 
following SS-induced tinnitus (Chen et al., 2012). It is not fully understood what changes 
could cause this gain. The present study showed an increase in the level of GABAB 
receptors in both the amygdala and hippocampus. The increase in activity can be due to 
the increase in GABAB receptors, specifically presynaptic GABAB receptors (see section 
4.2 for details).  
 The limbic structures are connected to CAS, forming a neural circuit. The CAS 
forms a neural circuit as well in which they are also connected to each other. Change in 
 94 
neural activity in one structure an affect others found in the neural circuit. Hyperactivity 
in the limbic structures can cause an enhancement in the CAS. It is likely that such an 
increase can lead to an enhanced synchronization and an epileptic form of firing 
responses. Such responses can be speculated to be responsible for tinnitus sensation.  
4.5.2 Other functions (e.g., emotion, memory etc.) 
 The main roles of the amygdala and hippocampus are in emotion and memory, 
respectively. Regulation of neural activity is required throughout the CNS for appropriate 
higher order functioning (Gerken et al., 1984; Bauer et al., 1999). Therefore, it is highly 
possible that SS-induced tinnitus can affect these functions. An enhanced level of 
GABAB receptors as observed in the present study can lead to a change in neural activity 
and consequently a change in higher order functions.   
A study found strong correlations between tinnitus and stress, anxiety, and 
depression. Individuals with tinnitus have reported to be stressed due to the condition 
(Langguth, 2011). More research is required on understanding how memory is affected 
due to tinnitus. It is highly probable that there may be a decrease in memory formation. 
Many subjects that report tinnitus, explain a hard time concentrating. Since concentration 
is required during memory formation, it may become more difficult and require a longer 
period of time for those with chronic tinnitus to consolidate their memory.   
Not much evidence exists for the changes tinnitus can cause to emotion and 
memory. Future research should focus on how SS can affect these functions. 
Understanding this can lead to possible clinical methods designed to help patients battling 
with emotional distress or who have trouble forming memories.  
 95 
4.6 Possible cellular mechanisms underlying changes in the level of the GABAB 
receptors 
 As noted in this study, there was an increase in the level of GABAB receptors, 
following a systemic application of SS. Many proteins are required to allow this increase 
to happen. Previous studies have examined other proteins and their changes to proteins 
due to SS-induced tinnitus. In the amygdala, two immediate early genes were studied: 
arg3.1 and c-fos (Mahlke and Wallhausser-Franke, 2004). Following SS-induced tinnitus, 
the genes showed an increase in expression. These genes are required in many biological 
functions and its possible that they aid in synthesis of GABA/GABAB receptors. In 
another study, an increase in GAD1 levels was observed in the hippocampus after SS-
administration (Im et al., 2007). The enzyme GAD1 is required to synthesize GABA; 
therefore an increase in GAD1 is an indirect indication of an increase in GABA. An 
increase in the neurotransmitter could indicate that it is upregulated because it is required 
to bind functional GABAB receptors.  
4.7 Conclusions and Future directions  
A systemic application of SS can lead to an increase in the level of GABABR1 
and GABABR2 subunits in the amygdala and hippocampus three hours later. The drug 
causes a larger change in the amygdala than the hippocampus. These findings can help us 
understand the induction/manifestation of SS-induced tinnitus. Furthermore, they 
strongly suggest that further research should be conducted to examine how SS can cause 
changes in other functions of the brain such as emotion and memory. 
The current study focused on how SS changed the level of GABABR1 and 
GABABR2 subunits. Further experiments should be conducted by using techniques such 
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as immunofluorescence double labeling and ligand binding. Double labeling can give 
insight to if the two receptor subunits are co-localized and forming heterodimers, which 
can give a firm conclusion about SS changes the level of functional receptors. Ligand 
binding can also be used to examine the effect of SS on functional receptors in the limbic 
structures.  
 Other experiments should be conducted to examine whether SS primarily affect 
pre- or postsynaptic GABAB receptors. From the current study it was inferred that the 
drug-induced increase maybe due to presynaptic auto-receptors. To confirm these 
findings, experiments should be designed to label both GABAB receptors and other pre- 
or postsynaptic proteins in PS- and SS-treated animals. In this way, a more definite 
answer as to whether pre- or postsynaptic GABAB receptors are mainly affected by a 
systemic application of SS can be obtained. Furthermore, patch-clamp recordings can be 
used to examine whether blocking of GABAB receptors leads to the change in the 
neurotransmitter release in PS- and SS-treated animals. All the experiments described 
above will all help enhance our understanding of the effect of SS on the level and 
function of the GABAB receptor in limbic structures. 
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TABLES 
 
Table 1: Summary results of OD values of the molecular layer of the cerebellum.  
 
 GABABR1 GABABR2 
PS-treated 39.83 40.33 
SS-treated 47.33 50.00 
 
 
 
 
 
Table 2: Summary results of normalized OD values of overall changes in the amygdala  
 
 GABABR1 GABABR2 
PS-treated 0.3136 0.2762 
SS-treated 0.5456 0.4756 
 
 
 
 
 
Table 3: Summary results of normalized OD values of overall changes in the major 
subdivisions of the amygdala labeled against GABABR1 
 
 BLA BMA CeN LaN 
PS-treated 0.2733 0.3982 0.3412 0.2418 
SS-treated 0.5159 0.5238 0.6314 0.5112 
 
 
 
 
 
Table 4: Summary results of normalized OD values of overall changes in the major 
subdivisions of the amygdala labeled against GABABR2 
 
 BLA BMA CeN LaN 
PS-treated 0.2907 0.3272 0.2325 0.2543 
SS-treated 0.4698 0.5005 0.4149 0.5171 
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Table 5: Summary results of normalized OD values of cell bodies in the major 
subdivisions of the amygdala labeled against GABABR1 
 
 BLA BMA CeN LaN 
PS-treated 0.8167 0.9500 0.9500 0.7250 
SS-treated 1.0917 1.1833 1.2700 1.0167 
 
 
 
 
 
Table 6: Summary results of cell density (in cell bodies per square millimeter) in the 
major subdivisions of the amygdala labeled against GABABR1 
 
 BLA BMA CeN LaN 
PS-treated 25 41 43 36 
SS-treated 36 46 51 38 
 
 
 
 
 
Table 7: Summary results of normalized OD values of cell bodies in the major 
subdivisions of the amygdala labeled against GABABR2 
 
 BLA BMA CeN LaN 
PS-treated 0.8667 0.9750 0.7700 0.7500 
SS-treated 1.3500 1.4417 1.2800 1.2100 
 
 
 
 
 
Table 8: Summary results of cell density (in cell bodies per square millimeter) in the 
major subdivisions of the amygdala labeled against GABABR2 
 
 BLA BMA CeN LaN 
PS-treated 38 38 48 34 
SS-treated 46 45 57 48 
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Table 9: Summary results of normalized OD values of overall changes in the 
hippocampus 
 
 GABABR1 GABABR2 
PS-treated 0.3768 0.4976 
SS-treated 0.4555 0.5977 
 
 
 
 
 
Table 10: Summary results of normalized OD values of overall changes in the major 
subdivisions of the amygdala labeled against GABABR1 
 
 CA1 CA2 CA3 DG SUBd SUBv 
PS-treated 0.3516 0.4090 0.4312 0.3520 0.2975 0.4195 
SS-treated 0.4697 0.5483 0.5026 0.3842 0.3743 0.4540 
 
 
 
 
 
Table 11: Summary results of normalized OD values of overall changes in the major 
subdivisions of the amygdala labeled against GABABR2 
 
 CA1 CA2 CA3 DG SUBd SUBv 
PS-treated 0.4741 0.5717 0.4892 0.4567 0.4386 0.5551 
SS-treated 0.5958 0.6248 0.6049 0.5447 0.5235 0.6925 
 
 
 
 
 
Table 12: Summary results of normalized OD values of cell bodies in the major 
subdivisions of the amygdala labeled against GABABR1 
 
 CA1 CA2 CA3 DG SUBd SUBv 
PS-treated 0.9750 0.9517 1.0200 1.0333 0.9083 0.9500 
SS-treated 1.1750 1.1417 1.2500 1.2333 1.1167 1.2000 
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Table 13: Summary results of cell density (in cell bodies per square millimeter) in the 
major subdivisions of the amygdala labeled against GABABR1 
 
 CA1 CA2 CA3 DG SUBd SUBv 
PS-treated 28 58 44 19 38 40 
SS-treated 33 71 44 21 47 39 
 
 
 
 
 
Table 14: Summary results of normalized OD values of cell bodies in the major 
subdivisions of the amygdala labeled against GABABR2 
 
 CA1 CA2 CA3 DG SUBd SUBv 
PS-treated 1.10 1.11 1.16 1.08 1.04 1.15 
SS-treated 1.42 1.43 1.53 1.41 1.43 1.55 
 
 
 
 
 
Table 15: Summary results of cell density (in cell bodies per square millimeter) in the 
major subdivisons of the amygdala labeled against GABABR2 
 
 CA1 CA2 CA3 DG SUBd SUBv 
PS-treated 27 42 36 32 46 42 
SS-treated 29 53 43 34 46 44 
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APPENDICES 
Solutions needed for immunohistochemistry experiments:  
0.5M Sodium Phosphate Dibasic 
For 1L:  
 70.98g sodium phosphate dibasic powder (NaH2PO4H2O) 
 1L of diH2O 
0.5M Sodium Phosphate Monobasic  
For 1L:  
 68.99g anahydrous sodium phosphate monobasic (NaH2PO4) 
 1L diH2O 
0.4M Sodium Phosphate Buffer (PB) (pH=7.2) 
For 1L:  
 600mL 0.5M sodium dibasic solution 
 200mL 0.5M sodium phosphate monobasic solution 
 200mL diH2O 
0.1M Sodium Phosphate Buffer (PB) (pH=7.2) 
For 1L:  
 250mL 0.4M PB 
 750mL diH2O 
0.1M Phosphate Buffer Saline (PBS) (pH=7.2) 
For 1L: 
 250mL 0.4M PB 
 750mL diH2O 
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4% Paraformaldehyde (PFA) in 0.1PB (pH=7.2) 
For 1L:  
 40g PFA powder 
 1L 0.1M PB 
  PFA can be dissolved into the PB by heating on a stir plate at a low heat 
setting. pH can be adjusted by adding HCl or NaOH.  
Cyroprotectant solution  
For 100mL: 
 30g sucrose  
 100mL PB 
0.05% Triton in 0.1M PBS (TPBS) 
For 1L: 
 0.05mL Triton X-100 
 1L 0.1M PBS 
3,3’ diaminobenzidine tetrahydrochloride (DAB)-nickel solution 
For 20mL: 
 5mL 0.4M PB 
 200µL 0.4% NH4Cl in 0.1M PB  
 200µL glucose  
 13.6mL diH2O 
 200µL 50mg/ml DAB in 0.1M PB 
 0.8mL 1% Nickel sulfate in diH2O 
 20µL glucose oxidase  
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